Polymorph Function in Ankylosing Spondylitis by Mowat, Lynda G
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
Polymorph Function in Ankylosing Spondylitis
by
Lynda G. Movat
being a thesis submitted for the degree of 
Master of Science 
in the 
University of Glasgow 
University Department of Medicine 
Royal Infirmary 
Glasgow 
August 1990
ProQuest Number: 11007417
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11007417
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
This thesis is dedicated
to my father
Thomas G.S. Parry
ACKNOWLEDGEMENTS
I should like to express my thanks to the following friends and 
colleagues.
Dr. R.D. Sturrock for affording me the opportunity to undertake this 
degree.
Dr. C.G. Gemmell and Dr. R.D. Sturrock for their support and guidance.
Susan Lennie, Margaret Frame and Suzanne McLellan for their consistant 
encouragement.
Dr. R. Madhok for his help and endless supply of normal "volunteer” 
blood samples, many of which were kindly donated by my friends and 
colleagues in The Department of Medicine.
John Smith for his general advice, and Andy Jenkins for computing 
advice.
The Medical staff and patients of the C.R.D.
My dear sister, Barbara Sharp, for her time and expertise in the 
typing of this thesis, and to Offshore Drilling Supplies, Aberdeen for 
the use of their word processing equipment.
To John for his help,and to my sons for fending for themselves on so 
many occasions.
gwwnary
The possible role of gram-negative bacteria in the causation of
seronegative spondyloarthropathies, and the response of polymorphs to 
gram-negative bacteria in ankylosing spondylitis, forms the basis of 
this study.
Polymorph response to arthritogenic gram-negative bacteria in
ankylosing spondylitis patients were examined by comparing them to
HLA-B27 positive and negative healthy controls, and to a group of 
rheumatoid arthritis patients.
Bacteria used in the assays had either a speculative or clear
association with the seronegative spondyloarthropathies.
Three different assays were used in this study to evaluate
i) Polymorph motility
ii) Polymorph chemiluminescence response to various stimuli and
iii) Phagocytic ingestion of radio-labelled gram-negative bacteria.
No difference was shown in motility between ankylosing spondylitis and 
normal polymorphs, although a culture filtrate of K. pneumoniae was 
shown to have some chemotactic quality. In addition phagocytic 
ingestion of enteric bacteria by polymorphs from ankylosing 
spondylitis patients was similar to normals. Therefore no
abnormalities were shown in either the motility or phagocytic capacity 
of ankylosing spondylitis polymorphs.
Initial studies using isolated polymorphs showed no difference in 
chemiluminescence response between patients and normal controls. A 
whole blood assay was then refined for use in this study, and 
chemiluminescence basal response was shown to be significantly 
increased in ankylosing spondylitis polymorphs compared to normal 
polymorphs. This indicated a pre-activation of normal polymorphs 
during the cell separation procedure, in our initial studies; thus 
concealing any inherent difference in chemiluminescence response 
between patient and normal polymorphs. Subsequent assays also showed 
a significantly enhanced chemiluminescence response in ankylosing 
spondylitis patients polymorphs compared to normals following 
stimulation with gram-negative bacteria and S . aureus. Contrastingly 
polymorphs from patients with rheumatoid arthritis showed an increase 
only to S. aureus. These results could indicate that gram-negative 
bacteria may contribute to an enhanced chemiluminescence response in 
ankylosing spondylitis patients, which is not specific. In addition, 
chemiluminescence response did not differ between HLA-B27 positive and 
negative normals, suggesting that enhanced activation develops with 
disease, rather than being inherent.
Conclusions suggest a chronic activation and exposure of ankylosing 
spondylitis to gram-negative triggers.
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CHAFTER 1 INTRODUCTION
1.1. ANKYLOSING SPONDYLITIS
The term ankylosing spondylitis (AS) is derived from the Greek 
'ankylos* meaning crooked and 'spondylos' meaning vertebrae. It is a 
chronic inflammatory disorder and the pathology is dominated by 
restricted spinal movement and ultimate ossification in the 
thoracolumber region (Ball, 1971). Involvement of the sacroiliac joint 
is the hallmark of the disease, and this becomes immobilised as a 
result of repeated bouts of inflammation of the entheses (bone- 
ligament junction) followed by bone deposition. Peripheral joints are 
involved at some stage of the disease in as many as 35% of 
patients,(Wilkinson & Bywaters, 1958), namely hip & shoulder joints. 
Other peripheral joints are relatively infrequently involved in 
primary AS, and tend to resolve without any residual joint deformity 
in most patients. The most common extraskeletal involvement in AS 
patients is acute anterior uveitis which occurs in 25% of patients at 
some time during the course of the disease (Khan et al 1981). The 
majority of patients with AS report onset of symtoms in their late 
twenties, early thirties, with only 5% or so beginning after the age 
of 50 years. (Wilkinson, and Bywaters 1958).
Management of the disease is directed at the suppression of pain and 
stiffness with non-steroidal anti-inflammatory drugs and a life-long 
exercise programme, to prevent or minimise the deformities of the 
spine, which are inherent in the disease.
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1.1.1. Epidemiology
The prevalence of the antigen HLA-B27 in AS patients varies from 
population to population. The highest known prevelence of B27 in 
normals is in the Haida Indians of British Columbia, of whom 50% carry 
the B27 antigen (Gofton: et al 1975). Navajo Indians have a 36% 
frequency of B27 (Rate et al 1980), and in both populations, 10% of 
the males develop A.S. Where the antigen is rare, as with the 
Australian aborigines and South American Indians, AS is rarely seen 
(Khan 1985).
Only 9% of normal Caucasian populations possess the antigen B27, and 
80% of normal, healthy, B27 positive people do not develop AS. 
Therefore clearly the presence of the antigen itself is not sufficient 
to cause the disease.
Ankylosing spondylitis is more predominant in males than in females. 
Wright and Mall in 1973 suggested a sex ratio of 8/10 males to 1 
female. More recent studies suggest that the disease has been grossly 
underdiagnosed, especially in females, and clinical features of AS 
are found to evolve more slowly in women than in men, thus male : 
female ratio may be closer to 7:3 (Hill et al , 1976) and (Van der
Linden, 1984).
Familial aggregation has been demonstrated for AS, suggesting the 
disease is genetically inherited (Calin 1985, Wright 1978), and
the relatives of probands with spondylitis have the disease more 
frequently than would be expected from the normal population. In a
2
survey of 76 probands with AS 3.6% of 250 first degree relatives age 
15 years and over, had clinical AS compared to 0.18% of a control
population. The relative risk was 20. (Emery and Lawrence, 1967).
A genetic mechanism alone however could not account for the
pathogenesis of AS, as monozygotic twins have been shown to be
discordant for the disease. (Eastmond and Woodrow 1977). This 
indicates environmental factors are also involved.
1.1.2. Genetics and HLA Status
The major histocompatibility complex of humans, a multigene family, 
known as the human leucocyte antigen (HLA) system, is located on 
chromosome 6 and codes for three classes of cell surface glycoproteins 
which control several important immunological functions (fig. 1).Class 
1 antigens, HLA-A,B,C, are involved in tissue graft rejection since 
they are recognised as foreign substances by cytotoxic T-cells (Swartz 
BD, 1982).
The HLA-D region codes for class II proteins and these are involved in 
antigen presentation to helper T-cells.
Class III antigens are important components of the complement pathway, 
and are mediators of acute inflammation.
In 1973 Brewerton et al and Schlosstein et al simultaneously reported 
an association of HLA-B27 with AS. Although the significance and the 
molecular basis of this association of HLA-B27 with AS is still not
3
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understood, there are two main theories.
i. The two gene theory which proposes that an associated or linked 
immune response gene near the B27 locus on chromosome 6, is in 
'linkage disequilibrium1, rather than randomly associated, with B27 
(Benacerraf and McDevitt 1972), (McDevitt and Bodmer 1974). Its gene 
product somehow mediates the development of AS. This association 
provides a selective advantage which maintains the genetic link. 
However no such gene product has been identified. As the disease gene 
cannot be defined by its structural properties, only its functional 
properties of being associated with the disease, no investigation to 
test for the presence of the gene product, defined by the AS gene, has 
been designed. Nor does this theory explain AS patients who do not 
have the B27 gene.
ii. The one gene theory suggests that the B27 gene product is 
directly involved in the disease and either resembles an antigen from 
some environmental agent eg. a micro-organism (cross tolerance 
hypothothesis) or may act as a receptor for foreign antigens. Interest 
in the involvement of a micro-organism in the aetiology of AS was 
stimulated by an initial report from Ebringer et al (1976), which 
suggested that there was cross-reactivity between HLA-B27 positive 
(B27+) lymphocytes and several gram-negative bacteria. Klebsiella 
pneumoniae, they found, could be more frequently isolated from the 
bowel flora of AS patients than normals, especially when the disease 
was 'active' (Ebringer et al 1977). Such micro-organisms are thought 
to initiate the production of antibacterial antibodies that bind to 
self antigens, activating the complement cascade, thus inducing
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inflammatory disease (Ebringer 1983). Kuberski et al (1983) also 
reported an increase in faecal carriage of K .pneumoniae in 'active' AS 
and Reiters syndrome (RS).
However some groups have been unable to substantiate these findings 
e.g. Eastmond et al 1978, and Warren and Breweron 1980 failed to show 
a significant difference in the isolation rates of K.Pneumoniae in 
the bowel flora of AS patients to normals. Beaulieu et al 1983 failed
to show any cross-reactivity between antisera raised to HLA-B27
lymphocytes and K.pneumoniae. Nevertheless it has been recognised 
that bacterial infections can trigger spondylarthritis. This is 
clearly demonstrated in Reiters syndrome (RS) where gram-negative 
bacteria, including Salmonella (Stein et al 1980) and Yersinia 
(Chalmers et al 1978) have been clearly implicated in the onset of the 
disease. The high association of AS and HLA-B27 is also found in many 
other forms of seronegative inflammatory disease (Ebringer 1980). 60%
of patients with RS and 90% who develop arthritis after enteric 
bacterial infection are HLA-B27 positive. 50% of those with acute 
anterior uveitis (AAU) and 100% with AAU and AS also possess this
antigen. However the strongest association remains between AS and 
HLA-B27. The true interaction between cell surface structures and
micro-organisms is still not understood. Geczy et al in Australia 
have shown that an antiserum to an isolate of K. pneumoniae is 
cytotoxic for lymphocytes from AS patients with HLA-B27 positive 
antigen, but not from HLA B27 negative patients or from HLA B27
positive or negative normals. (Geczv et al. 1980). These cross
reactivity experiments have been validated in Sydney, where cells from 
the UK, Netherlands and New Zealand were correctly identified as being
5
spondylitic, using Geczy's Klebsiella antisera (Archer et al 1985; Van 
Rood et al 1985; McGuigan et al 1986a). This cross-reactivity also 
occurs with other enteric bacteria ( Prendergast et al 1983, 1984;
McGuigan et al 1986). From their results Geczy suggested that 
several species of enteric bacteria share a common factor which is
related to an HLA-B27 associated cell surface structure on AS
patient's cells. Welsh et al 1980 confirmed this theory by shoving 
that serum raised to B27 positive lymphocytes cross reacted with 
antigens on various bacteria.
An immune response initiated by an invading microbe may also react 
with a normal host protein, where the linear amino acid sequences are 
homologous. HLA-B27 has been found to share six consecutive amino 
acids with K. pneumoniae nitrogenase by comparing the sequence of HLA- 
B27 with bacteria pathogens in the Dayhoff protein sequence data bank. 
(Schvimmbeck et al. 1987). They also shoved a significant correlation 
between B27 positive individuals with AS and the production of
antibodies to the homologous area, common to both HLA-B27 and K.
pneumoniae. This was not the case with healthy B27 positive 
individuals. These results suggest that an immune response, directed 
initially against a Klebsiella infection, would also react against 
homologous HLA-B27 sequences in the host, thus explaining the high 
incidence of HLA-B27 in AS patients, and providing a potential 
pathogenic mechanism for the disease.
However, the association between AS and enteric bacteria still remains 
to be further confirmed by other independent sources before micro­
organisms can be said to play a key role in AS pathogenesis.
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CHAPTER 1.2 ENTEROBACTERIACEA
1.2.1. Cell Wall Structure
The enterobacteriaceae by definition are gram-negative, non - sporing 
rods, sometimes motile. They inhabit the gastrointestinal tract of 
man, either as bowel commensals, or as pathogens, and may or may not 
be capsulated. The bacterial cell is a rich source of antigenic 
determinants, and many species exhibit antigenic variation. The most 
important antigens are those associated with the cell surface, and 
these form part of the structure of the bacterial membrane, 
periplasmic space, vail or envelope and are concerned with protection 
against adverse physiological conditions, such as extremes of pH, 
dessication, temperature changes, and phagocytosis. In addition, 
external structures, such as caspular or slime layers, fimbrae and 
flagella, interact with the environment to allow the bacteria to 
establish their situation.
The cell wall of gram-negative bacteria is much more complex than that 
of the gram-positive bacteria, which is a relatively simple structure 
composed of roughly equal proportions of peptidoglycan, which is 
responsible for the shape and strength of the cell wall, and an 
anionic polymer, which is covalently linked to muramic acid residues 
on the peptidoglycan network.
The gram-negative envelope consist of a thin layer of peptidoglycan, 
next to the cytoplasmic membrane. Outside this is the outer membrane 
(OM) consisting of protein, phospholipid and lipopoly-saccharide (LPS)
7
which is connected to the peptidoglycan layer by covalently linked, 
low molecular weight lipoproteins (Fig II).
The o-somatic antigen is an endotoxic LPS, which is located in the 
outer leaflet of the outer membrane. It is the major surface antigen, 
partially responsible for the strength and shape of the cell wall, and 
forms the basis for serological classification. The structure has 
been extensively studied and numerous reviews are available e.g. 
Rogers et al 1980. Basically it consists of three parts:
1. A hydrophobic lipid A region which remains fairly constant in 
nature from species to species.
2. A hydrophilic 0 - specific polysaccharide (O-antigen), which is 
made up of oligosaccharide repeating units, consisting of a short 
linear main chain, with or without single hexose branch substitutes, 
permitting immense antigenic variability.
3. A core oligosaccharide region that connects lipid A and the 0- 
antigen, and shows more variability in structure than that of 
bacterial lipid A.
1.2.2. Permeability.
Permeability of the 0M toward hydrophilic nutrients is due to porins 
(Nikaido and Nakae 1979), a special group of proteins which span the 
0M forming pores or channels, permitting only passage of molecules of 
a certain size. Their exclusion limit is low in enteric bacteria, and
8
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Fig II Crcss-secticn of the envelope of a typical Gram-negative 
bacterium (taken from Lambert IS33).
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phospholipid; LPS. lipopolysaccharide; 0, 0 antigenic 
polysaccharide of LPS.
little is known about factors which control their functional state. 
There are two pathways by which agents can permeate the OM; a 
hydrophilic pathway via the aqueous pores, and a hydrophobic pathway 
involving diffusion across the OM layer. The more hydrophilic the 
bacterial cell surface, the more resistant is the organism to 
phagocytosis.
1.2.3. Capsular polysaccharides.
Two types of capsular polysaccharides are found in enteric bacteria. 
The M antigen or colonic acid is made only under adverse physiological 
conditions, which indicates that enteric bacteria make it only when 
situated outside the animal intestinal tract.
The other type is the K-antigen. the classical serotype specific 
polysaccharide. This provides a highly hydrated gel-like coat around 
the cell which protects it from phagocytosis and dessication. However 
it does not prevent the penetration of nutrients. Capsulated bacteria 
grow as rapidly as non-capsulated strains, and appear to have a 
central role in adhesion to surfaces ( Costerton et al 1981).
Polysaccharide capsules are antiphagocytic as a result of their 
hydrophilic nature. Surface polysaccharides also protect bacterial 
cells from the bactericidal action of complement and antibody. This 
is well established for the yi antigen of Salmonella tvphimurium (see 
Dudman 1977).
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1.2-.,4, Flagella and Flmbrae In Enterobacterlaceae
Flagellar (H) antigens are present in motile species and consist of 
protein subunit polymers of flagellin. Flagellins from different 
species are antigenically distinct. Some genera e.g. Proteus. possess 
a sheath structure, surrounding the flagellar filament, which is
antigenic.
Fimbiial antigens enable bacteria to adhere to the surface of cells 
possessing the appropriate receptors, e.g. enterobacteriaceae with 
common type 1 Mannose - sensitive fimbiae adhere to many kinds of 
cells other than erythrocytes. Most animal, plant and fungal cells 
serve as substrates for such organisms. Certain non- fimbriates of 
salmonellae are pathogenic, whereas fimbriate strains can be isolated 
from normal healthy subjects.
1.2.5. Infections
During inflammation, reactions of tissues to an infection may be 
divided into purulent and granulomatomous forms.
Purulent infections are characterised by short duration, acute course 
and the accumulation of polymorphonuclear leucocytes (PMNs) at the 
sites of bacterial invasion. Disease subsides after PMNs and 
mononuclear phagocytes have phagocytosed the bacteria, and killed them 
within phagolysosomes. These bacteria are known as extracellular 
bacteria and include cocci, as well as the gram-negative rods found 
in many infections.
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Faculative intracellular bacteria, the best known being Mycobacterium 
tuberculosum and Mycobacterium leprae, elicit granulomatomous tissue 
responses and also include the Yersinia species and Salmonella 
tvphimurium. These bacteria survive after phagocytosis, within the 
PMNs and initially in the mononuclear phagocytes, and as a result 
cause chronic, cyclic, systemic disease.
1.3. COMPOSITION OF HUMAN BLOOD.
Normal human blood is a suspension of complex cellul. r components 
suspended in an aqueous medium called plasma. When anticoagulated 
blood is allowed to settle, it separates into three major 
constituents: plasma, red cells (erythrocytes), white cells
(leucocytes) and platelets. The complex nature of blood is reflected 
in its many diverse functions.
Transport and exchange of gases.
Transport of nutrients, hormones and enzymes.
Removal of waste products.
Maintenance of body temperature.
Provision of defence mechanisms against infection or haemorrhage.
1.3.1. Plasma. Platelets and Red Cells.
Plasma and serum are the aqueous fractions of anticoagulated and 
clotted blood respectively. They both have essentially the same 
composition except that fibrinogen and some clotting factors have been 
removed from the plasma. Platelets are the smallest of the circulating
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bodies, are non-nucleated and are usually round or oval in shape. 
Activated platelets aggregate to help seal a damaged vessel, a 
reaction which occurs within seconds of an injury. Red cells are the 
most numerous in blood, and are involved in the transport of oxygen. 
Red cells are produced from a stem cell in the bone marrow, a process 
called erythropoiesis. They share this precursor with white cells, 
whose production is termed lymphopoiesis.
1.3.2. White cells.
White cells consist of five cell types;
Neutrophils, eosinophils, basophils, monocytes and lymphocytes.
Neutrophils, eosinophils and basophils are collectively known as 
granulocytes, and all contain lobed nuclei.
Neutrophils have the most lobed nuclei and are commonly referred to as 
polymorphonuclear leucocytes (PMNs). They are the most numerous of 
the white cells and their major function is the destruction of micro­
organisms. They migrate from the blood to sites of inflammation via 
a process called chemotaxis. Once at an inflammatory site, they 
engulf the invading organisms in a vacuole formed by invagination of 
the cell membrane (phagocytosis). Phagocytosed material is then 
killed and degraded by enzymes produced by this vacuole and the cells 
cytoplasmic granules. Polymorphonuclear leucocytes spend only a few 
hours in the blood before migrating into the tissues where they may
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survive for 3-4 days. When they are in the blood they can be freely 
circulating or marginated along blood vessel walls. The total pool of 
PMN is composed of approximately equal numbers of circulating and 
marginated cells. Morphology and function will be further discussed in 
chapter 5.
1.3.2.2. Eosinophils
Eosinophils are much less numerous than PMNs, and are distinguishable 
by their large reddish brown cycoplasmic granules. Their function is 
not well understood, but they are involved in IgE immune responses 
(e.g. allergic disorders), responding to basophil and most cell 
degranulation by neutralising the released inflammatory mediators.
1.3.2.3. Basophils
Basophils are the least numerous of the peripheral blood leucocytes, 
and are identified by large violet staining granules. They are 
similar to most cells, and both bind specific IgE to their cell 
surface. Further exposure to specific antigen results in rapid 
degranulation, with release of histamine and other mediators involved 
in hypersensitivity reactions.
1.3.2.4. Lymphocytes
Lymphocytes are the most heterogeneous of the leucocytes; most are 
small (6-7um) with a high nucleo-cytoplasmic ratio. There are two 
major types; T cells (Thymus dependent) and B cells (bursa or bone
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marrow dependent), which are concerned with cell mediated and humoral 
immunity respectively. Lymphocytes differ from granulocytes in 
several respects. For example, many lymphocytes re-circulate (i.e. 
re-enter the blood from the tissues) and many can live for several 
years.
1.3.2.5. Monocvtes
Monocytes are maturing cells released from the bone marrow and are 
able to migrate to the tissues where they can survive for long 
periods, accumulating at the sites of chronic imflammatory reactions. 
Average diameters of monocytes are around 7-8um, with solid kidney­
shaped nuclei. They differ from granulocytes in that they have only 
small cytoplasmic granules and possess other cytoplasmic organelles 
(e.g. mitochondria, rough endoplasmic reticulum) which enable them to 
live in the tissues for long periods as macrophages.
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CHAPTER 2. MATERIALS AND METHODS.
COLLECTION OF SAMPLES.
A velcro fastening rubber tourniquet was applied to the subjects arm, 
giving gentle pressure to aid the puncture of an ante cubital vein.
Using either a 19 or 21 gauge sterile disposable needle (Becton, 
Dickinson & co., Ltd.) or similar gauge butterfly needle (Abbott 
Ireland Ltd.) blood was slowly drawn into a sterile plastic syringe 
(Becton-Dickinson Ltd., U.K.). The whole blood samples were collected 
into universals (Lab Sales (U.K.) Ltd.) containing preservative free 
sodium heparin (1,000 units/ml, Leo Labs, U.K.), 50ulbeir^used per 5 
ml of blood. Tubes were stoppered and gently mixed. All blood 
samples were taken between 09.00 and 11.00 hours to minimise the 
effect of diurnal variation, and samples were processed as soon as 
possible after collection.
2.2. SEPARATION MEDIA
2.2.1.Dextran 150
A 5% dextran 150 (Fisons UK) solution was made in 0.9% saline (Sodium 
chloride B.D.H. Ltd. England.) When dissolved this solution was 
filtered, using a 0.22 micron disposable, sterile filter assembly 
(Gelman Sciences, USA), into a sterile bottle, and stored at four 
degrees centigrade.
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2.2.2. Lymphoprep.
Lymphoprep (LP) is a ready made sterile solution (Nycomed, Norway) 
with a density of 1.077 g/ml and an osmolarity of 300 rdPsp/Kg.
2.2.3. Ammonium Chloride
Ammonium chloride ( NH«C1, Sigma) was prepared as an 0.87% solution in 
distilled water, and stored at 4°C.
2.2.4. Gel Hanks
10ml of Hanks Balanced Salt solution (lOx) (HBSS, Gibco Ltd., 
Scotland) without salts, was added to 80 mis of sterile distilled 
water. 2 ml of Hepes buffer (lHsolution, Gibco) and 1.1ml of Sodium 
bicarbonate solution (Northumbrian Biologicals Ltd., UK) were added to 
stabilize the solution.
This was adjusted to PH 7.2 with a Normal sodium hydroxide (BDH Ltd., 
England) and 1 Normal Hydrochloric acid (BDH, sp:gr. 1.18).
lOmls offijgelatin (BDH Chemicals, UK) was added to prevent aggregation 
of cells. This solution (GH) will remain stable for several days.
2 ^  SEPARATION OF POLYMORPHONUCLEAR LEUCOCYTES (Pmns)
Polymorphonuclear leucocytes were prepared from heparinised venous 
blood samples,using a modification of the method of Boyum (1968).
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10 ml of blood was mixed with 3ml of the 5% dextran (2.2.1.) in 15 ml 
conical based centrifuge tubes (Elkay products Ltd., USA), and allowed 
to gravity - sediment for 30-45 minutes, at ambient room temperature.
The red blood cells settled at the bottom of the tube, while the 
leucocyte-rich plasma remained at the top. (Fig 111).
This plasma was then layered on to 3ml of lymphoprep (2.2.2.), and 
centrifuged ( Mistral 4L, MSE UK) at 289g for 25 minutes.
After centrifugation the mononuclear cells settled at the interphase, 
and the PMNs pelleted at the bottom of the tube. (Fig IV)
The supernatent was discarded and NH«C1 (2.2.3) was added for 20
minutes, to lyse any remaining red blood cells that had not sedimented 
out in the dextran .&5kfhen washed with GH, and adjusted to required 
concentration of cells, as follows.
2.4. COUNTING METHOD
Using a light microscopy method (Dacie and Lewis, 1966), 10 ml of cell 
suspension is diluted in 90 ml of white cell fluid (2% V/V solution of 
glacial acetic acid in distilled water, to which a few grains of
crystal violet have been added).
The number of cells (Y) in the 4 x outermost corners of 16 x squares, 
on the grid of a Neubauer chamber was estimated, and the mean
calculated. (40 x magnification) Watson microsystem 70). This is
17
Fi
g.
 in
 
D
ex
tra
n 
se
di
m
en
ta
tio
n 
of 
wh
ol
e 
blo
od
 
pjg
 
Ly
m
ph
op
re
p 
se
pa
ra
tio
n 
of 
le
uc
oc
yt
e-
ric
h 
pl
as
m
a.
multiplied by the dilution factor (1:10) and then by 10* to give the 
number of cells per ml present i.e. y x 10 x 10* cells per ml. Where 
whole blood was being used in an assay, a differential white cell 
count was done, again using a Neubauer chamber, as follows.
A total cell count was done followed by a mononuclear cell count.
Concentration and percentage of polymorphonuclear leucocytes present 
could thus be calculated.
2.5. BACTERIA
2.5.1. Growth Media
Mueller Hinton broth (MH, oxoid, UK) was prepared by adding 21grams 
per litre to distilled water, and autoclaving at 121° centigrade for 
fifteen minutes. Blood agar plates, and cysteine lactose electrolyte 
deficient medium (Cl.ED) plates were used to maintain the bacteria, 
single colonies of which were inoculated onto fresh plates every two 
weeks.
2.5.2. Diluting and Washing Duffer
Phosphate buffered saline tablets (PBS), (Oxoid,UK), were dissolved in 
distilled water ( 1 tablet per 100 ml), and autoclaved at 121°C for 
fifteen minutes and stored at 40°C.
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2.5.3. Standardisation of Bacteria
Four gram-negative and one gram-positive bacteria were used in this 
work, namely,
1. Klebsiella pneumoniae, strain K43
2. Proteus roirabilis
3. Yersinia enterocolitica
4. Salmonella tvphimurium
5. Staphvloccocus aureus. Covan strain
Suspensions of known concentration had to be determined for each 
bacterium.
This was achieved by preparing a series of culture dilutions, made 
with a constant dilution factor (Miles and Misra 1938).
A bacterial suspension of known optical density (OD) was prepared in 
PBS, and 10-fold dilutions from this were made. Spectrophotometer was 
set at 620nm, slit width O.lnm.
lOul from each dilution were then placed on an agar plate, and 
incubated overnight at 37°C. Colony forming units (C.F.U.)were 
counted the next day and the number of bacteria per ml in the original 
sample calculated.
i.e. C.F.U. x diluting factor x 100 = required O.D.
This was repeated several times until OD for each bacterium was 
standardised for concentration of 1 x 10*7 CFU/ml and 1 x 10* CFU/ml 
(Fig. V).
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Optimum %
I_J& IQTgftf/ml___1 x 10*cfu/ml opsonin
K, pneumoniae 0.015 0.1 50
P. mirabilis 0.025 0.045 50
Y. enterocolitica 0.01 0.05 10
£-» tYPhlffVfflVffP 0.01 0.05 10
S. aureus 0.1 10
Fig. V. Optical densities and percentage
dilution and opsonisation of each bacteria.
for
2.5.4. Normal Pool Serum for opsonisation of bacteria.
A normal pool serum (NPS) was established by bleeding 7-10 volunteer 
healthy individuals. Serum was separated by centrifugation at 2020'g' 
for 10 minutes, then aliquoted and stored at -70°C.
Several dilutions of NPS were then tested for opsonisation of each 
bacterium until the optimum percentage of NPS was standardised for 
both bacterial uptake and chemiluminescent response. (Fig.V).
In our uptake assay, S. tvphimurium failed to opsonise with NPS.
This was overcome by using a rabbit antiserum raised to a known 
enterobacterial common antigen (EGA) positive strain of Escherichia 
coli, which successfully opsonised the bacteria at a concentration of 
10%. Enterobacterial common antigen is an amphiphilic 
glycophospholipid located in the outer membrane of almost all wild 
type strains of the Enterobacteriaceae, and its expression on the cell 
surface is readily available to homologous antibody in non­
encapsulated rough strains.
2.6. CHEMOTAXIS AND CHEMOKINESIS
The membrane filter technique was first designed by Boyden in 1962 and 
then Falk in 1980 developed a micro-chem taxis assembly.
These assays were performed on 48-well micro-chemotaxis chambers, 
supplied by Neuro Probe inc., U.S.A. (See Fig VI)
Nucleopore polycarbonate filters for use in these chambers are
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Fig VI Micro-chemotaxis chamber.
available in a range of pore sizes, according to which cells were 
being examined.
For our purposes 3u pore, lOu thick filters were used for PMN
migration.
Various chemotaxins were placed in the lower wells of the chamber,
using an automatic pipette pre-set at 26ul, and care was taken to 
avoid the formation of any air bubbles on the surface. The meniscus 
should be slightly raised. The membrane was then applied, shiny side 
down, allowing the centre portion to make contact first. Minq* 
adjustments to the filter position could be made at this point.
The silicon gasket and the top plate were secured in place by
maintaining an even pressure until all the screws had been tightened 
to prevent air being introduced into the system.
A slide was then placed over the wells and the chamber allowed to 
equilibrate at 37°C in a 5% mixture of OOa and air for 10 minutes 
(water-jacketed incubator, Scotlab Ltd., UK). Cells were prepared to 
the desired concentration, as described in 2.3, and 50pl were added to 
the top of the chamber, again carefully avoiding the introduction of 
any air bubbles by holding the pipette at an angle against the upper
part of the well and ejecting the fluid rapidly.
Further incubation of the uncovered chamber followed for 30 minutes. 
Screws were removed and chamber was inverted on to a paper towel, and 
the membrane removed; the migrated cells now faced upwards. The 
lower side was then washed 3xtimes in PBS and excess Rnns were wiped
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off, using a filter wiper (Neuro Probe inc., U.S.A.). The membrane 
was left to dry in air, then fixed in methanol, A.R. quality (James 
Burrough F.A.I. Ltd., UK) for 2 minutes, and stained with 100% 
Leishmans stain (Exogen, LHC) for 5 minutes. Then 50% Leishmans for a 
further 5 minutes.
After drying, the membrane filter was mounted in D.P.X. (B.D.H. Ltd., 
UK) and the number of cells present in each well was estimated in 5 x 
fields under a 40 x objective. Each test was done in triplicate, and 
the mean result calculated. Chambers should be placed in sterile 
distilled water immediately after use, then washed in distilled water 
and left to air dry.
PHAGOCYTIC UPTAKE ASSAY
Phagocytosis was measured by a modification of the method of Verhoef 
et al (1977)
2.7.1. Preparation of bacteria
One colony of bacteria was inoculated into 10ml of Mueller Hinton (MH) 
broth, containing 20ul 3H adenine (Radiochemical Centre, Amersham). 
This was incubated overnight at 37° centigrade, where the bacteria 
incorporate the radioactively-labelled adenine into their own genome. 
Bacteria were then washed x 3 in Phosphate buffered saline (PBS), and 
centrifuged at 1200'g ’ (MSE, Super minor, UK) for 15 minutes.
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The bacterial suspension was then diluted until the appropriate 
optical density (OD) was obtained on a spectrophotometer (Unicam, SP 
1700), set at 620nm and slit width O.lnm (see 2.5.3.).
2.7.2. Opsonisation of bacteria
The bacteria were now ready for opsonisation with a normal pool serum 
(NPS). Equal volumes of diluted NPS (see 2.5.4.) were added to the 
bacterial suspensions, and placed on a shaking incubator at 37° 
centigrade for 15 minutes. These were centrifuged at 1200'g' for 15 
minutes. The supernatent was removed and the pellet re-suspended at 
the original volume of bacteria, in gel-hanks.
2.7.3. Assay
0.1 ml opsonised radio -labelled bacteria and 0.1 ml of pran suspension 
(prepared as described in 2.3, at 1 x 107/ml) were added in duplicate 
to two sets of polypropylene scintillation vials (Pony vial, Canberra 
Packard, UK) and placed on a shaking incubator for 15 minutes at 37°C 
Phagocytosis was terminated in one set of vials by the addition of 
3mls PBS at 4°C and then centrifuged at lOOOrpm for 5 minutes. This 
was repeated three times, and after the last wash 3ml scintillation 
fluid was added (299 from Canberra Packard, UK). The purpose of these 
washes was to remove any free bacteria, i.e. non-phagocytosed 
bacteria, which would not be spin down at lOOOrpm, thus only those 
bacteria which were leucocyte- associated would remain. The vials 
were counted on a scintillation 3 counter (1216 Rackbeta II (LKB,UK)] 
for 1 minute each. These counts were referred to as low counts.
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The duplicate set of vials were assessed for total bacterial 
radioactivity, by the addition of 3ml scintillation fluid, immediately 
after the uptake period (i.e. no washes). These were also counted for 
one minute per vial and were referred to as high counts.
A further set of duplicated vials, containing 0.1 ml bacteria and
0.1ml Gel Hanks were similarly treated for high and low counts, to
give a reading representing non-specific bacterial adherence to the 
tubes and aggregation. These were referred to as blank values. (FIG 
Via).
2.7.4. Calculations for determination of phagocytosis
The % uptake of bacteria was calculated as follows.
Formula 1
counts per min low counts
% uptake test  ------------------------  x 100
counts per min high counts
The above formula was also applied to the blank tubes and the final
value for the blanks was subtracted from the test values.
Formula 2
% uptake = % c.p.m. test - % c.p.m. blank
These formulae gave the final readings for percentage uptake of 
bacteria by PMNs, and all results were expressed in this manner.
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Stages VIAL 1 VIAL 2 VIAL 3 VIAL 4
©  100 ul PMN 100 ul PMN
at 1 x10 7 /ml at 1x10 7/ml
100 ul GH 100ulG H
© 100 ul b a c t  (1 x107 /ml) added to all vials
Incubate at 3 7 ^  for 15 minutes©
©  Add Wash x3 Add Wash x3
scintillation with phosphate scintillation with phosphate
fluid buffered saline fluid buffered saline
© Add
scintillation
fluid
Add
scintillation
fluid
©  Amount of radioactivity was determined using a 
liquid scintillation counter
©  Results expressed as phagocytic uptake
% uptake. x100) _ ( 5 x  100)
cpm viall cpm vial 3
Fig Via Outline of phagocytic uptake assay.
CHEMILUMINESCENCE
Chemiluminescence (CL) was measured using a luminometer, Picolite 
(Packard U.K.), which consists of 2 units, a detector and an analyser. 
This model is an automatically programmable instrument used to measure 
single photons of light, emitted by certain biological and chemical 
reactions. It requires a clean dry air supply that delivers a minimum
of 60-80 psi to drive the carousel.
Two types of assays were performed, using luminol (5-amino- 2, 3-
dyhydro-1, 4-phthalazinedione) at 10-s as an amplifier, which is
converted to an excited aminophthalate ion in the presence of 
oxidising species like superoxide anion (02) hydrogen peroxide
(H2O2 ), hydroxyl radical (-OH), and singlet oxygen (i02): thus
enabling trace amounts of activated oxygen species to be measured 
(Allen et al 1976).
2.8.1. Purified PMNs
In our first series of assays we looked at purified PMNs, and their 
reaction to gram-negative bacteria.
Bacteria were prepared as described in 2.5.3.at a concentration of 1 x 
10* colony forming units (cfu) per ml, and opsonised with appropriate 
dilution of NPS (2.5.4.). Polymorphonuclear leucocytes were also 
prepared (2.3) at 1 x 107 per ml, i.e. a minimum ratio of 1:10, PMNs 
to bacteria. The exact ratio was not crucial/ as long as it was 
maintained throughout the assays.
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It was important that patients and normal samples were run 
simultaneously, as results do vary from day to day.
100 ul PMNs were added, in sequence, to the luminometer chambers.
These were left for a short time to equilibrate at 37°C - i.e. the 
temperature within the carousel. Meanwhile the programme.u)a& set on the 
computer, according to length of time between readings, number of 
readings and automatic injection of the bacteria, if required.
Bacteria in these assays were added manually as four types were used
in each run. Computer was also primed with sample information and 
contents of each chamber.
lOOul of luminol (Sigma) at 10“* molar was added, following by lOOul 
of opsonised bacteria.
The CL. responses were measured in peak counts per second at 1x10*. CL 
curves and absolute peak responses were produced automatically by the 
computer.
Peak counts per second were taken for each sample and these results 
were analysed using a Mann Whitney U Test.
2.8.2. Whole Blood Assay
In this series we used heparanised whole blood samples, rather than 
isolated PMNs.
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A differential white cell count was done on each sample, using a 
Neubauer chamber, determining number of PMNs and percentage PMNs, 
present in each sample (2.4).
Opsonised Bacteria was prepared, as before at lxlO*/ml.
The Picolite analyser was primed with previously calculated PMNs data 
and the computer set for a whole blood assay. This time 20ul of whole 
blood was added to the Picolite chambers followed by 50ul of gel
hanks, lOOul bacteria and lOOul of 10”B luminol.
Results again were taken as peak count per second at lxl03/ml, for 
each sample, and analysed according to Mann-Whitney. See Fig VII for 
methodology and Fig VIII for example of computer print out of results.
2.9 BLOOD SAMPLES
2.9.1. Ankylosing spondylitis (AS) Patients
Throughout these assays samples were taken from AS patients, who were 
either attending the Rheumatology clinic^ or who were undergoing 
treatment in the wards. All patients were informed that samples were 
required for medical research.
Classical AS patients, as described by the New York criteria were 
used, and a disease scoring activity was devised by rheumatologists
from the Centre for Rheumatic Diseases. Other disease parameters
were taken into account as well as biochemical and haematological
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CHEMI LUMINESCENCE
PURIFIED PMN 
(dextran sedimentation) 
100 pi
WHOLE BLOOD PMN 
(heparinised)
20 pi
Equilibrate at 
37 °C for 10 mins
100 pi stimulus 
(eg opsonised bacteria, PMA)
100 pi luminol x 10“^
35 mins in luminometeri
Readings from luminometer 
at 5 min intervalsl
Peak CPS for each sample
Fig VII Chemi luminescent methodology.
W H O L E  B L 0 0 D / K 4 3
chanber 1 ■ 2 <=• 3 o 4 *
2 1 / 1 0 / B B
l.e+04
cps
tine (Min)
P r o g r a m  £ 4 ,  9  c y c l e s
5  s e c o n d s  c o u n t  t i m e ,  w i t h  5  m i n u t e s  c o u n t  d e l a y
I d e n t i f i c a t i o n W B C / m l XPHC c h a m b e r p e a k  ( m i n ) p e a k  c p s
N 1 + K 4 3 6 . 1 0 e + 0 6 6 6 . 0  1 1 5 2 . 9 2 e + 0 3
N 2 + K 4 3 1 . 0 0 e + 0 7 6 6 . 0  2 1 5 5 . 2 0 e + 0 3
A S 1 + K 4 3 1 . 0 0 e + 0 7 7 0 . 0  3 1 5 9 . 9 9 e + 0 3
A S 2 + K 4 3 1 . 0 0 e + 0 7 7 4 . 0  4 1 0 9 . 56e-<-03
I d e n t  i f i c a t  i o n c h a m b e r a r e a h a l f — m a x  ( m i n )
N 1 + K 4 3 1 4 . 5 5 e + 0 6 3 0  -  3 5
N 2 + K 4 3 2 7 . 6 3 e - K > 6 2 5  -  3 0
A S 1 + K 4 3 3 1 . 5 8 e + 0 7 3 0  -  3 5
A S 2 + K 4 3 4 1 . 4 2 e * 0 7 2 5  -  3 0
0 . 0 4  
0 . 0 4  
0 . 0 7  
0 .  0 6
Fig VIII Example of computer print-out of chemiluminescent 
results from luminometer.
data, i.e. peripheral joint involvement, drug therapy and the general 
well-being of the patient. Consequently a more global determination 
of disease was achieved. Scoring for each section was between zero 
and two, making a total maximum score of 10. (See Fig. IX).
2.9.2. Normal Controls
Samples from AS patients were compared at all times, to normal 
controls, which were obtained from laboratory and medical "volunteer” 
staff.
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AS DISEASE ACTIVITY SCORE
NSAIDS None/occasional 0
Regular 1
Peripheral joint None 0
involvement Previous 1
Current 2
Morning back pain/ None 0
stiffness <1 hour 1
>1 hour 2
ESR <30 0
30-60 1
>60 2
CRP <10 0
10-50 1
>50 2
IGS Normal 0
Elevated 1
Maximum score = 10
Fig IX Disease activity score.
CHAP!ER 3 CHEMOTACTIC RESPONSE OF NORMAL AND ANKOLYSING 
SPONDYLITIS POLYMQRPHQNlId .FAR LEUCOCYTES TO
VARIOUS CHEMOATTRACTANTS
itl* CHEMOTAXIS
Chemotaxis (CX) is the directional locomotion of organisms in relation
to sources of chemical attractants, (Zigmond, 1974). The capacity of 
leucocytes to move in response to chemotactic stimuli is an essential 
part of host defence against infection, (Ward 1974), whereby cells 
are attracted to sites of tissue injury. Polymorphonuclear leucocytes 
(Pmns), which show good chemotactic responsiveness, are the most 
numerous of the leucocytes in blood and are easily obtained in high 
yield and purity. These cells appear also to be homogenous, behaving 
alike on stimulation. On addition of a chemotactic factor the cells 
become polarised into an anterior lamellipodium and posterier tail. 
This is accompanied by contractile waves which move down the cell from 
front to back. Receptor redistribution also occurs where the cell 
contents move to the front end of the cell. (Wilkinson, Michl and 
Silverstein, 1980). A high degree of cell deformability contributes 
to the ability of the PMNs to leave the capillary lumen by squeezing 
between the capillary endothelial cells and moving into the tissue 
(diapedesis). Polarisation and redistribution are the earliest 
visible responses of a leucocyte to environmental signals.
Introduction of micro-organisms into tissue results in the production 
of factors to which the PMNs respond due to high affinity receptors on 
their surface. These factors are either products of microbial 
metabolism e.g. formyl peptides, complement proteins, or products of
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the phagocytes themselves. (Snyderman and Gaetze, 1981). The 
complement system is the most important known source of chemotactic 
factors in vivo, from which is derived C5a fragment and factor Ba (a 
fragment of factor B resulting from action by factor D). Other 
plasma- derived mediators with chemotactic activity include the 
Hageman factor-dependent substances, kallekrein and plasminogen 
activator, and by-products of arachidonic acid metabolism. Cell- 
derived chemotactic factors include lymphocyte, monocyte and PMN 
products, (Ward, 1974). Also in certain tissue, bacterial and viral 
products contain C3- and C5- cleaving enzymes which can indirectly 
result in the release of complement - derived chemotactic factors. 
Chemotactic factors may contribute to deformability of PMNs. (Kawaoka, 
Miller and Cheung, 1981).
Locomotion is either random or directed. Stimulated random movement 
(chemokinesis) occurs when a chemoattractant interacts with a 
leucocyte in the absence of a concentration gradient^ whereas 
chemotaxis is a unidirectional movement in response to the 
concentration gradient of a chemo-attractant. Chemotactic direction 
finding in PMNs is very efficient and cells in good gradients move in 
near straight-line paths towards the gradient source, (Allan and 
Wilkinson, 1978). Thus chemotaxis is an excellent mechanism for 
directing cells towards loci of infection or tissue injury.
Studies of locomotion and chemotaxis in monocytes and lymphocytes have 
advanced at a much slower rate, although both are important in chronic 
inflammation and in immune reactions. Heterogeneity is a major 
problem with both cell types, and of course high cell yield and purity
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are less easily obtainable than with PMNs.
The first observation of chemotaxis was reported by Leber in 1888, 
and has been studied in vitro on slides or coverslips (Harris, 1953), 
in capillary tubes (Ketchel and Favour, 1955), in culture wells under 
agarose (Cutler, 1974) and by a membrane filter technique, first 
described by Boyden in 1962. Falk in 1980, developed a 48-well micro 
chemotaxis assembly which had many advantages over other methods, such 
as time involved in setting up the assay, volume of chemotactic factor 
needed, and low cell number requirements,(see chapter 2.6)for details 
of method used in this study.
Despite an initial report that there was no significant difference in 
polymorph motility between AS and controls (Mowat, 1978), there have 
been several reports documenting significant increases in PMN mobility 
in AS. Pease et al. in 1984 showed that directed movement of PMNs was 
significantly increased in AS patients whether they were HLA-B27 
positive or negative. Reports from Finland also indicated that not 
only was the in vitro chemotaxis of HLA-B27 positive PMN significantly 
increased over HLA-B27 negative PMN normals, but that sera from HLA- 
B27 positive subjects were capable of significantly increasing random 
mobility, or chemokinesis, of PMN in comparison to HLA-B27 negative 
sera. (Leirisalo, et al. 1980, Repo et al. 1982). It has also been 
shown that increased PMN motility occurs in vivo in HLA-B27 positive 
individuals (Koivaranta et al , 1984) using a skin chamber technique.
Consequently it has been proposed that such hyperreactive PMNs may 
trigger a vicious circle of inflammation and thereby contribute to 
tissue injury in HLA-B27 associated diseases.
31
3.2. AIMS OF STUDY
To compare the motility of AS PMNs to normal PMNs using various 
chemotaxins. Results were analysed by a Mann Whitney, two-tailed, 
non-parametric test, and expressed as medians and inter-quartile 
ranges.
1*3* PREPARATION OF CHEMOTAXINS
Several preparations were tested for their use as chemotaxins.
3.3.1. Zvmosan-Activated Sera
125mg zymosan + 5ml of a normal pool serum were incubated for 60 
minutes at 37°C, then centrifuged at 750g for 10 minutes. The 
supernatant was then inactivated by incubation for 30 minutes at 56°C, 
and used at a dilution of 1/16 in gel hanks.
3.3.2. Formalin Killed Bacteria
K. pneumoniae and Y enterocolitica were cultured in MH broth 
overnight at 37°C, then washed x 3 in PBS. 1% formalin was added and 
left at room temperature for 24 hours, when a sample was plated out to 
test for loss of viability. Optical density was then adjusted to 
achieve 1 x 10*/ml dilutions for each bacteria, see chapter 2.5.3.
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3.3.3. Sonicated bacteria
1 x 10e/ml dilutions of K. pneumoniae and Y. enterocolitica were 
prepared in lOmls of gel hanks. These were centrifuged at 1200'g^or 
15 minutes and re-suspended in 1ml gel hanks. This preparation was 
then sonicated at 12 microns for 10 minutes, and re-suspended in lOmls 
of gel hanks.
3,3.4. Bacterial culture filtrates
K. pneumoniae. Y. enter ocolitica and S. typhimurium were cultured in 
MH broth overnight at 37°C, then centrifuged at 1200'g' for 15 
minutes. The supernatents (culture filtrates) were aliquoted, and 
stored at -20°C.
2-tAs. CHEMQKINETIC RESPONSE OF 10 NORMAL AND 11 AS
PATIENT PMNS
Chemokinesis, or random chemotaxis, was examined in 10 normals and 11 
AS patients to compare random mobility.
3.4.1. Materials and Methods
Samples were collected in heparin, PMNs separated, and prepared at 
3.5 x 10s/ml in gel hanks. These were placed in the bottom wells of 
the microchemotaxis chamber, and gel hanks was added at the top, so 
that no gradient was formed. Migration of PMNs were measured on 5 
fields per well. The mean result of 3 wells was calculated for each
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sample, and these were analysed using a Mann-Whitney test. 
Details of samples were as follows:
Earaals_________________ as
No. of Samples 10 1 1
Meap_ftqs (yrs) 3 2 48
range (25 - 43) (29-77)
M 7 9
Sex
F 3 2
3.4.2. Results
Results are expressed as medians and interquartile ranges. See Fig X. 
Patients showed an increased chemokinetic motility when compared to 
normals, but this increase was not statistically significant.
3.5. FORMALIN KIDDED AND SONICATED BACTERIA
No chematactic gradient was achieved when either sonicated or formalin 
killed bacteria were used as chemotaxins. Therefore no motility was 
produced and no results obtained.
3.6. BACTERIAL CULTURE FILTRATES
These were prepared with K. pneumoniae. Y. enter ocolitica and S*. 
tvphimurium. (as described in 3.3.4.).
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CHEMOKINESIS 
10 norms and 11 AS 
Mean of 
three wells
80 n
p = 0.06
60"
40-
20-
Normal AS
Chemokinetic response of polymorphonuclear cells from 
10 normals and 11 ankylosing spondylitis patients.
Expressed as medians and interquartile ranges.
3.6.1. Materials and Methods
Samples of heparinised-blood were collected from 11 normals and 15 
A.S. patients. Cells were separated and prepared at 5 x 10*/ml, and 
motility of normal PMNs was compared to AS PMNs. Details of samples 
were as follows:
Nojmal__________ AS
No. of Samples 11 15
Mean aae (vrs) 30 40
(range) (22-43) (32-59)
M 8 11
Sex
F 3 4
3.6.2. Results
Results are again expressed as medians and interquartile ranges. No 
significant difference was seen in motility between normal PMNs and AS 
patient PMNs when any of the bacterial culture filtrates were used as
chemotaxins. The chemotactic values of Y enterocolitica and S^
tvohimurium were similar to that of MH broth, indicating that these 
two bacteria on their own had no chemotactic qualities. K. pneumoniae 
culture filtrate, however, showed a higher chemotactic response than 
MH broth, suggesting that some product of this bacterium behaved as a
chemotaxin to both normals and AS patients. (Fig. XI).
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Fig XI Chemotactic response of polymorphonuclear from 11
normals and 15 ankylosing spondylitis patients, to 
K. pneumoniae (K43), Y. enterocolitica (yers) and
S. tvphimuriujD (salm), culture filtrates.
Expressed as medians and interguartile ranges.
IxjL. gHEEjQTACTIC RESPONSE OF PMNS FROM HLA B27 
POSITIVE AND HLA-B27 NEGATIVE INDIVIDUALS 
WITHOUT DISEASE.
Since more than 90% of AS patients are HLA-B27 positive, it is 
important also to examine HLA-B27 positive normals. Bacterial culture 
filtrates were again used as chemotaxins and samples from HLA-B27 
positive and HLA-B27 negative normal individuals were collected and 
PMN motility examined.
3.7.1. Materials and Methods
Culture filtrates from K . pneumoniae. Y. enterocolitica. and S. 
tvphimurium were prepared as desribed in 3.3.4. Samples from nine 
HLA-B27 positive and nine HLA-B27 negative normal individuals were 
collected in heparin. Polymorphs were separated by dextran 
sedimentation and prepared at a dilution of 5 x 10*/ml in gel hanks. 
Both positive and negative HLA-B27 normals were assayed simultaneously 
using micro-chemotaxis chambers.
3.7.2. Results
No difference in motility was seen between HLA-B27 positive and 
negative normals when bacterial culture filtrates were used as 
chemotaxins. Again, as seen with patient and normal groups, only £. 
pneumoniae appeared to show any chemotactic abilities. Results are 
expressed as medians and interquartile ranges. (See Fig. Xll).
36
No
.o
f 
c
e
l
l
s
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9 B27+ve and 9 B27-ve normals
Mean of 
three wells
p = 0.7
1601
140-
120- p = 0.1
100- p = 0.2
80* p = 0.1
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40-
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K43 YERS SALM.MH BROTH
Fig XII Chemotactic response of polymorphonuclear cells from 
9 B27 positive and 9 B27 negative normals to 
K. pneumoniae (K43), Y. enterocolitica (yers) and 
S. tvphimurium. culture filtrates.
(SrlM)
Expressed as medians and interquartile ranges.
3.8. ZYMOSAN - ACTIVATED SERA
The motility of AS and normal were compared using zymosan-activated 
serum as a chemotaxin.
3.8.1. Materials and Methods
Samples of heparinised blood from both normals and patients were 
collected and assayed simultaneously. Polymorphs were separated 
using dextran sedimentation (2.3) and prepared at a dilution of 3.5 x 
10*/ml for chemotaxis, (2.6). Zymosan was prepared at 1/16 (3.3.1.). 
Details of samples are as follows:
Normal__________________A£
No. of Samples 22 27
Mean acre (vrs) 30 44
range (23-43) (27-73)
M 9 20
Sex
F 13 7
3.8.2. Results.
Results showed no difference in motility between patient and normal 
PMNs (see Fig Xlll), and are expressed as medians and interquartile 
ranges.
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22 norms and 27 AS 
Mean of 
three wells
200 n
p = 0.1
150-
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50-
Normal AS
Fig XIII Chemotactic response of polymorphonuclear cells from 
22 normal and 27 ankylosing spondylitis to zymosan- 
activated serum (ZAS).
Expressed as medians and interquartile ranges.
3.9. AGE CORRELATION
Correlation of motility of normal PMNs to age was examined using a 
Spearman Rank test.
3.9.1. Materials and Methods.
The ages of 20 normal controls were correlated with motility of the 
PMNs, when zymosan-activated serum was used as a chemotaxin, (3.8.1.).
3.9.2. Results.
A poor correlation was evident, the Spearman rank coefficient being - 
0.44. We can be confident that this is a good estimate of correlation 
as the significance level was 0.05. (See Fig. XIV).
lOfi DISEASE ACTIVITY
Correlation of motility of AS PMNs to disease activity using a 
Spearman rank test.
3.10.1. Materials and Methods
Disease activity from 12 AS patients was scored according to the 
method described in chapter 2. This was compared to the motility of 
these AS PMNs when zymosan-activated sera was used as a 
chemoattractant.
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Correlation of motility to age in 20 normals
Motility
2501
sr = -0.4
200-
150-
100-
50-
20 25 30 35 40 45
Age
XIV Correlation of polymorphonuclear cells motility to age 
in 20 normals.
Spearman rank coefficient (sr) = -0.4.
Significance level, P = .05.
Motility
Sr corr. = 0.1
300*
200-
100-
0 4 62 8
Disease activity
Fig XV Correlation of polymorphonuclear cells motility to
disease activity in 12 ankylosing spondylitis patients.
Spearman rank coefficient (Sr. corr.) = 0.1
Significance level, P = 0.7
3.10.2. Results
The Qpearman rank correlation was 0.01 indicating no correlation 
between disease activity and PMN motility.
3.11 CONCLUSIONS
Random motility was increased in AS compared to normal, but this 
increase did not reach statistical significance (Fig. X).
Both formalin -killed, and sonicated bacteria showed no chemotactic 
value at all. Also bacterial culture filtrates proved not to be very 
successful chemotaxins, and only K . pneumoniae showed some 
chemotactic properties. Culture filtrates prepared from Y. 
enterocolitica and S. tvohimurium showed no chemotactic properties, 
in fact they appeared to inhibit the chemotactic value of MH broth 
(Fig. XI). In all cases no difference in motility was shown between 
AS PMNs and normal PMNs.
Polymorph motility between HLA-B27 positive and HLA-B27 negative 
normal individuals were similar, and again K. pneumoniae showed 
better chemotactic qualities than the other bacterial culture 
filtrates (Fig. XII). Only bacterial culture filtrates were examined 
as chemotaxins in this section, as HLA B27 positive normal samples are 
difficult to obtain.
When zymosan-activated serum was used as a chemoattractant, again no 
difference was observed between the motility of AS PMNs to normal 
PMNs. (Fig. XIII).
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No correlation was found between age and PMN motility in normals, 
between disease activity and motility in AS patients.
nor
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CHAPTER 4. CHEMILUMINESCENT RESPONSE TO VARIOUS STIMULI OF
POL YMORPHONIJCT .FAR LEUCOCYTES FROM NORMAL
SUBJECTS AND FROM PATIENTS WITH ANKYLOSING 
SPONDYLITIS.
CHEMI LUMINESCENCE
Chemiluminescence was first described by Allen et al in 1972 when he 
determined that stimulation of the hexose monophosphate shunt 
correlated with generation of observed light. This phenomenon has 
become a basic tool for measuring phagocytic action, as well as for 
assaying substances likely to influence the activity of activated 
oxygen. When interaction occurs with particulate or chemical
stimulation, PMNs respond with a chain of events known as the 
respiratory burst. Oxygen is taken up from the surrounding media, and 
under the influence of a membrane-associated pyridine nucleotide 
oxidase (NADPH/NADH oxidise) is rapidly converted to several active 
oxygen species (Babior et al, 1981): namely superoxide anion (Os-)
singlet oxygen (^Oa), hydroxide radical (OH) and most important for
microbicidal activity, hydrogen peroxide (H2 O2 ), (Klebanoff, 1980), 
which is a stable, membrane permeable, powerful oxidant. (See Fig 
XVI) .
Human PMNs contain a high concentration of myeloperoxidase (MPO), the 
enzyme that gives a greenish colour to abscess fluid. Klebanoff and 
Hamon in 1972, showed that H2 O2 reacts with MPO, in the presence of a 
halide (e.g. chloride) to form oxidised chlorine ions which allows 
destructive halogenation or oxidation of substrates.
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Also in the presence of NH«+ or amino acids such as taurine, MPO and 
H2 O2 can react to form N-chloroamines which appear to act as long 
lived microbicidal products (Weiss et al. 1983).The H202 - MPO -
halide system is thought to be the major bactericidal peroxidative 
mechanism in the PMNs. A system of detoxifying substances within each 
cell serves to protect against its own oxidants.
The relatively poor quantum yield of chemi luminescence (CL) can be 
amplified by the addition of luminol (5-amino - 2, 3 - dihydro - 1, 4
phthalazinedione), an organic substrate that produces light from post- 
phagocytic production of excited oxygen, enabling phagocytic oxidative 
activity to be measured in a sample (Allen and Loose, 1976).
Chemi luminescence has been shown to be quantitatively proportional to 
bacteria and neutrophil populations in phagocytic systems, and also to 
the concentration of luminol used (Quie, 1982).
As luminol can diffuse into the cell it can be used to monitor the 
production of both extracellular and intracellular hydrogen peroxide, 
Lucigenin, another organic substrate that produces light, behaves in a 
quite different way, essentially reacting with superoxide radicals, 
but unlike luminol it is unable to penetrate the cell thus reactipjoniy 
with extracellular superoxide.
Response of neutrophils to surface stimulation involves several 
aspects: release of activated superoxide; secretion of granule
components (myeloperoxidase containing azurophil granules); 
phagocytosis; and chemotaxis. Such a multiple response is triggered
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by several agents, either particulate or soluble. Neutrophil
membranes bear specific receptors for the Fc fragment of immune 
complexes and for particles opsonised with the C3b complement factor 
through the classical or alternate pathway. The effect of these 
physiological agents is mimicked by other agents, such as antibodies 
to neutrophil surface antigen and lectins (concanavalin A.) 
Chemotactic peptides (FMLP) stimulate the production and release of
oxygen derivatives as well as the secretion of granule material, while
other agents circumvent some of the steps involved in the activation
of the phagocyte, e.g. ca++ ionophores and phorbol esters.
All of these agents do not necessarily activate the same functions of 
the neutrophil, so the shape and time-course of the luminescence curve 
may vary. Zymosan (yeast cell walls) activated with serum through the 
alternate pathway of complement is probably the best established and 
most popular activator of phagocytes. Non--phagocytic membrane 
stimulation by soluble stimulants such as phorbol myristate acetate
(PMA) and FMLP are also used on a large scale but show different
profiles.
When tested at room temperature with luminol, FMLP induces bimodal 
peaks. The first peak corresponds to extracellular release of
myeloperoxidase (MPO) and hydrogen peroxide, and the second £>eak is 
related to the intracellular production of activated superoxide.
(Brieheim, 1984).
The diffusion of luminol to the intracellular compartment was thought 
necessary for the production of the second peak. The finding in some
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later work by Dahlgren, 1985 that lucigenin, thought incapable of
diffusing into the cell, is associated with only the first peak
substantiates this concept.
Microorganisms differ greatly in their susceptibility to killing by
oxidants. These differences are due in part to varying levels of
intracellular protective enzymes such as superoxide dismutase (SOD), 
catalase reductases and peroxidases. However it is not known whether 
any microorganism has sufficiently high levels of such enzymes to 
escape killing by PMN oxidants. They may be more likely to survive by 
blocking phagocytosis, inhibiting the respiratory burst or MPO, or by 
detoxifying agents.
The importance of the NADPH/NADH oxidase and MPO systems in 
microbicidal killing is exhibited in patients with chronic
granulomatous disease (CGD) whose PMNs ingest organisms normally, but
unless the organism itself produces hydrogen peroxide (eg
pneumococci), it is not killed (Mandell and Hook, 1969). This 
correlates with the knowledge that the PMNs of these patients do not 
manifest a respitory burst (Quie et al, 1967). Purified cell
preparations are normally used for CL studies, but a CL emission, 
which is primarily dependent on PMN activity, may be detected using 
whole blood in microlitre quantities. Kato et al, 1981, and Herberer 
et al. 1982 developed an assay of unfractionated whole blood CL for a 
simple and rapid evaluation of phagocytosis - induced metabolic 
respitory bursts which may rather reflect in vivo phagocytic functions 
under natural conditions. This method was used by De Chatelet and 
Shirley in 1981 to evaluate PMN function in C.G.D. patients. They
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stimulated the cells by adding PMA, which induces PMNs to behave as
they normally do during phagocytosis (De Chatelet et al, 1976), and
were able to quantify the luminescent response in microlitre 
quantities of whole blood and to demonstrate that cells from patients 
with CGD were not responsive to stimulation. The use of whole blood to 
detect phagocytosis has also been adapted for looking at the opsonic 
activity of serum (Stevens, 1981): by adding an appropriate bacterium 
and luminol to diluted whole blood it is possible to evaluate the 
opsonic activity of an added serum sample by measuring the light 
emitted during phagocytosis.
Chemiluminescence of whole blood has also been useful for monitoring 
patients with bacterial infections, Kohashi et al. 1987 and Tatsuhito 
Tono-Oka et al. 1983 showed that CL was signficantly elevated in 
patients with definite bacterial infections after stimulation with 
zymosan or PMA, compared to CL of blood from patients with viral 
infections or from normal healthy controls. Background CL was also 
elevated in patients with bacterial infections suggesting that PMNs 
were preactivated in vivo.
In this study the CL response of polymorphs, from patients with 
ankylosing spondylitis, to various stimuli, was compared to that of 
polymorphs from normal subjects.
All graphical results were expressed as medians and interquartile 
ranges.
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4.2. CHEMILUMINESCENT RESPONSE OF ISOLATED POLYMORPHS 
TO VARIOUS BACTERIAL STIMULI.
The aim was to isolate PMNs from AS patients, and from normal healthy 
controls, then to stimulate them by adding various bacteria to see 
whether or not any variations in CL response were detectable.
4.2.1. Materials and methods
Bacteria were standardised, as described in 2.5.3., prepared at 1 x 
10®/ml and opsonised with N.P.S. (See 2.5.4.). Both patient and 
normal samples were collected between 9 a.m. and 11 a.m. Cells were 
separated, prepared at 1 x lOVml (see 2.3.), and both patient and 
normal samples run simultaneously on the luminometer (see 2.8.1.).
Details of samples are as follows:
Normal Controls fts p?t;entg
No. of Samples 19 23
Mean Age (Yrs) 
range
29
(21-43)
46
(27-63)
M 9 20
Sex
F 10 3
4.2.2. Results
No significant difference was seen between normals and AS polymorphs 
with any of the four gram-negative bacteria tested, i.e. 
pneumoniae, P. mirabilis, Y. enterocolitica and § T typhilH\ttl.Unii
K . pneumoniae in particular showed a wide range of CL response for 
both normal and AS polymorphs, and also a higher response than the 
others. (See Fig. XVII). Results were analysed using a Mann Whitney 
test, and medians and inter-quart ile ranges were calculated.
4.3. CHEMILUMINESCENT RESPONSE OF ISOLATED POLYMORPHS AND
WHOLE BLOOD POLYMORPHS TO VARIOUS BACTERIAL STIMULI.
The aim here was to compare results of CL response from both isolated 
PMNs and whole blood PMNs using samples from AS patients and normal 
healthy controls, stimulated with bacteria.
4.3.1. Materials and Methods
K. pneumoniae, P. mirabilis. Y. enterocolitica and ?. typfrjmuEiuro were 
all standardised as described in 2.5.3, prepared at 1 x 10*/ml and 
opsonised with N.P.S. (see 2.7.2.). Samples from AS patients and 
normal controls were collected between 9-11 a.m.;
Details of samples are as follows:-
Normal Controls________ &£.Ea.Ufintg
No. of Samples 13 15
Mean Aae (vrs) 35 41
range (25-42) (26-59)
M 8 12
Sex
F  5 3
A differential count was done (2.4) on the whole blood from each
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Fig XVII Chemiluminescent response of purified polymorphonuclear 
cells from 19 normals and 23 ankylosing spondylitis 
patients to various bacterial stimuli.
Expressed as medians and interquartile ranges.
sample, then both patients and normals were assayed on the luminometer 
simultaneously. (See 2.8.2.).
Subsequently, purified PMNs from the same patients and normals were
separated from the whole blood (see 2.3.), and prepared at a dilution
of 1 x lOVml and CL response was estimated for these on the same day.
4.3.2. Results
N o  difference in CL response was seen, between patient and normal 
groups, when purified PMNs were stimulated with any of the four gram- 
negative bacteria, as was previously found. However CL response of 
the same samples using whole blood PMNs, was significantly enhanced in 
AS patients, for all bacteria (P <.05). Normal control whole blood 
PMNs appeared to remain inactive during bacterial stimulation. See 
Fig. XVIII for details. Medians and interquartile ranges were 
calculated, and a Mann-Whitney test was used to analyse the results.
4.4. CHEMILUMINESCENT RESPONSE OF WHOLE BLOOD
POLYMORPHS TO BACTERIAL STIMULI.
Further samples from AS patients and normals were collected and CL 
response to bacterial stimuli was examined to confirm the initial
whole blood assay results.
4.4.1. Materials and Methods
K. pneumoniae. P. mirabilis, Y. enterocolitica and S, typhimmriyim were 
all standardised, as previously described in 2.5.3, prepared at 1 x
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Comparison of CL response between separated PMNs from 13 controls and 15 
patients and CL response of whole blood PMNs from the same samples, 
performed on the same day, to various bacterial stimuli.
Measured as "Peak CPS"
10e/ml and opsonised with NPS (see 2.7.2.). Samples were collected 
between 9 a.m. and 11 a.m.;
Details of samples were as follows:
Controls_____________AS Patients
No. of Samples 17 20
Mean Acre (yrs) 33 43
range (25-42) (26-63)
M 10 16
Sex
F 7 4
A differential count was done on all samples (see 2.4.), then normal 
and AS samples were run on the luminometer simultaneously.
4.4.2. Results
Patient and normal controls were again analysed using a Mann Whitney 
Test and results confirmed our initial findings, that a significantly 
enhanced CL response was produced from the AS samples compared to 
normals, when cells were exposed to gram-negative bacteria. P Values, 
medians and I.Q. ranges were calculated.(See Fig. XIX).
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Fig XIX Chemi luminescent response of whole blood polymorphonuclear
cells from 17 normals and 20 ankylosing spondylitis 
patients to various bacterial stimuli, namely
K. pneumoniae (K43) Y. enterocolitica (Yers)
P. mirabilis (Prot) S,_ tvphlmurium (salm)
4.5. WHOLE BLOOD AND PURIFIED PMN BASAL CL RESPONSE
IN NORMALS AND AS PATIENTS.
Unstimulated whole blood and purified PMNs were examined for a basal 
CL response, to ascertain whether or not there was any variations in 
CL response between normals and AS patients.
4.5.1. Materials and Methods
Differential counts were done on whole blood samples, (2.4), then 
patients and normals were assayed simultaneously (2.8.2.).
Purified PMNs from five patients and five normals were subsequently 
examined for a basal CL response.
4.5.2. Results
Unstimulated whole blood AS PMNs showed a significantly enhanced 
response compared to normals, (P=.046), see Fig. XX.
Purified PMNs however showed no such enhancement, (see Fig XXI), 
indicating that the separation technique appeared to pre-activate the 
normal PMNs.
4.6. CHEMI LUMINESCENT RESPONSE OF WHOLE BLOOD
POLYMORPHS TO A GRAM-POSITIVE BACTERIAL
STIMULUS.
The next step was to see whether or not an enhanced CL response by AS 
PMN was restricted to stimulation by gram-negative bacteria.
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Whole blood basal chemi luminescent response of 
polymorphonuclear cells from 9 normals and 12 
ankylosing spondylitis patients.
Median and upper quartile value almost identical 
in normal polymorphonuclear cells.
Fig XXI
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Basal chemiluminescent response of purified polymorpho­
nuclear cells from 5 normals and 5 patients.
Expressed as medians and interquartile ranges.
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Therefore whole blood AS and normal PMNs were exposed to 
Staphylococcus aureus (COWAN strain), a gram-positive bacteria.
4.6.1. Materials and Methods
Samples were collected from normal controls and AS patients, on the 
same day. Details are as follows:
Controls_______________AS Patients
No of Samples 14 18
Mean Age (Yrs) 31 48
range (25-45) (29-64)
M 8 13
Sex
F 6 5
S. aureus was adjusted to a concentration of 1 x 10e/ml, and opsonised 
with N.P.S. (2.7). Again a differential count was done on each sample 
so that the percentage of PMNs present in each sample could be 
calculated. Controls and patient were then run together on the 
luminometer. (see 2.8.2.). A total of fourteen controls and eighteen 
AS patients were examined.
4.6.2. Results
Whole blood samples from ankylosing spondylitis patients showed a 
significantly enhanced CL response when compared to normal controls 
(P=.002). (See Fig XXI ).
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WHOLE BLOOD CL RESPONSE-S. aureus
14 NORMALS AND 18 AS PATIENTS
p=0.002
O'O'
NORMAL AS
pmn pmn
Whole blood chemi luminescent response of polymorpho­
nuclear cells from 14 normals and 18 ankylosing 
spondylitis patients to S. aureus.
Expressed as medians and interquartile ranges.
4.7. WHOLE BLOOD POLYMORPHONUCLEAR LEUCOCYTES 
STIMULATED WITH PHORBOL 12-MYRISTATE 13- 
ACETATE
Phorbol 12- myristate 13- acetate (PMA) is a membrane-active 
stimulator of oxidative metabolism that is used to study reactive 
oxygen species production, thus mimicking the action of phagocytosis 
and bacterial killing by PMNs, (Repine et al. 1974).
4.7.1. Materials and Methods
Phorbol 12-/nyristate 13- acetate was dissolved in dimethylsulfoxide 
(DMSO) to give a stock solution of 2.0 mg/ml. An aliquot diluted to 
the appropriate concentration with phosphate buffered saline (PBS) was 
prepared immediately prior to use.
A whole blood assay was performed as described in Chapter 2.8., adding 
50 nanograms of PMA rather than a bacterial stimulant.
Samples were collected from 24 AS patients and 12 normal controls. 
Details as follows:
AS Patients Normal Controls
No. of Samples 24 12
Mean Age (vrs) 
range
42
(25-69)
32
(22-43)
M 18 5
Sex
F 6 7
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4.7.2. Results
Results were analysed using a Mann Whitney test, and the CL response 
of AS whole blood PMNs was found to be significantly enhanced (P=.03) 
compared to normal controls, when stimulated with PMA. (See Fig
In order to establish whether or not this phenomenon was common to 
other inflammatory disorders, CL response was examined in rheumatoid 
patients when whole blood PMNs were stimulated with K . pneumoniae. P . 
mirabilis and S. aureus.
4.8.1. Materials and Methods
Bacteria were prepared at 1 x 10e/ml and opsonised with N.P.S. 
(Chapter 2.7.). Samples from Rheumatoid patients and normal controls 
were collected between 9 a.m. and 11 a.m. and assayed simultaneously. 
Details of patients and normal controls are as follows:
XXII )
4.8 CHEMI LIMINESCENT RESPONSE OF POLYMORPHS FROM 
RHEUMATOID PATIENTS.TO A BACTERIAL STIMULUS.
RA Patients Normal Controls
No. of Samples 14 10
Mean Age (vrs) 
range
62
(45-70)
35
(24-43)
M 4 4
Sex
F 10 6
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CL RESPONSE OF 12 NORMAL vs 24 AS PATIENTS 
PMA STIMULATION
4
3
2
0
AS PatientsNormals
p=0.03
Fig XXII Whole blood chemi luminescent response of polymorpho­
nuclear cells from 12 normal and 24 ankylosing 
spondylitis patients to Phorbol-rayristate-acetate 
(PMA).
Expressed as medians and interquartile ranges.
A whole blood assay was performed as in Chapter 2.8.
4.8.2. Results
Peak counts per second (CPS) were noted for each sample and results 
presented graphically. (See Fig. XXItt).
Results were analysed using a Mann Whitney test.
No difference was seen between RA patient and normals when cells were 
unstimulated indicating no in vivo preactivation. Similarly no
difference was seen between patients and normals when stimulated with 
either K. pneumoniae or P. mirabilis.
However an enhanced CL response was evident in RA patients compared to 
normal controls (P= .03), when stimulated with S. aureus, a gram- 
positive bacterium often associated with septic arthritis in patients 
with rheumatoid arthritis.
4.9. CHEMI LUMINESCENT RESPONSE OF HLA-B27 POSITIVE
AND HLA-B27 NEGATIVE NORMALS TO VARIOUS
STIMULI.
CL response was tested in HLA-B27 positive and negative normal
individuals to see whether or not enhanced CL enhanced response was 
related to HLA status.
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Fig XXIII Whole blood chemi luminescent response of polymorphonuclear 
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various bacterial stimuli.
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4.9,1. Materials and Methods
A whole blood CL assay was performed as previously described, and 
cells were stimulated with K. pneumoniae. P. mirabilis. £*. 
enterocolitica, S . typhimurium and with PMA consecutively.
Unstimulated cells were also examined.
4.9.2. Results
CL response was slightly enhanced in the HLA B27 positive normal 
samples for all stimulants. These differences however were not 
statistically significant. See Fig. XXIV for details.
4.10. DISEASE CORRELATION
4.10.1. Materials and Methods.
Disease activity was scored in fourteen AS patients, as described in 
Chapter 2.9.1.
Comparison of the CL response of whole blood PMNs, stimulated with K . 
pneumoniae was compared with disease activity. A Spearman rank test 
was used for analysis.
4.10.2. Results
Only a weak correlation was found, the correlation coefficient being
55
WHOLE BLOOD CL RESPONSE
9B27+ve AND 10B27 -ve NORMALS
Unstimulated
p=0.5
K.pneumoniae
p=0.5
Y.entercolitica
p=0.07
PMA
p=0.3
Positive
Negative
HLA-B27 normals
Fig XXIV Whole blood chemi luminescent response of polymorpho­
nuclear cells from HLA-B27 positive and HLA-B27 
negative normals to various stimulants.
PMA: Phorbol 12-myristate-13 acetate.
Expressed as medians and interquartile ranges.
CORRELATION OF CL RESPONSE TO DISEASE ACTIVITY IN 14 AS PATIENTS
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Fig XXV Spearman rank (sr) correlation of chemi luminescent
response to disease activity in ankylosing spondylitis 
patients.
Significance level (P) = .07.
0.5, perhaps due to two outlying values. See Fig. XXV . significance 
level or confidence level (P) = .07.
4.11. CONCLUSIONS
Initial results, using purified PMNs, showed no difference in CL
response between AS patient and normal subjects. This proved to be a 
result of the separation technique, which appeared to pre-activate the 
PMNs before bacterial stimulation, thus masking any enhancement of CL 
response in AS PMNs.
Comparison of CL response using whole blood PMNs and purified PMNs, 
from the same samples confirmed that this in fact was the case, and 
consequently whole blood was used in subsequent assays.
A significantly enhanced CL response was found in whole blood PMNs 
from AS patients compared to normal PMNs, when stimulated by the gram- 
negative bacteria, K. pneumoniae. P. mirabilis. Y. enterocolitica and 
S. tvphimurium. The next step was to see whether or not this result 
was exclusive to gram- negative bacteria. Therefore AS whole blood 
PMNs were stimulated with S . aureus. (Cowan strain), a gram-positive 
bacterium which is not arthritogenic. Again AS showed a significantly 
enhanced response indicating that this phenomenon was not specific to 
a gram-negative bacterial challenge.
When unstimulated whole blood PMN were examined for basal CL response, 
AS patients were found to be pre-activated in vivo. This was not the 
case when PMNs had been separated from the whole blood, as the
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separation technique activated the normal controls, thus no difference 
in basal CL response was seen between patients and normal PMNs. A non­
specific activation of PMNs at basal level in AS is evident, the 
trigger being unclear. An explanation for this could be that as a 
result of increased intestinal permeability, (Morris, A.J. et al 1989, 
unpublished) AS patients could be more susceptible to invasion by 
gram-negative bacteria asssociated with the gut,thus activating host 
defence mechanisms.
Since RA whole blood PMN do not show basal activation it would appear 
that this phenomenon is not specific to all chronic inflammatory 
disorders. Furthermore no enhanced CL response was ascertained with 
RA patients compared to normals, when whole blood was stimulated with 
gram- negative bacteria. However, when stimulated with S. aureus. CL 
response was found to be significantly greater in RA patients compared 
to normals.
Phorbyl 12- myristate 13- acetate, an active principle of croton oil, 
causes ultra- structural changes in PMN similar to those observed 
during phagocytosis (White and Estensen, 1974). When used as a 
soluble rather than a particulate stimulus, a significantly increased 
CL response in AS patients was shown, compared to controls.
When HLA-B27 positive and negative normals were examined, no 
significant difference was found in CL response, although there was a 
tendency for HLA-B27 positive PMNs to show an increased CL when 
exposed to gram-negative bacteria or PMA. No difference in basal 
activation was seen.
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Finally only weak correlation was evident between CL response to gram- 
negative bacteria, and disease activity.
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CHAPTER 5 PHAGOCYTIC UPTAKE OF RADIO-T.ARET.T.EP CRAM-
NEGATIVE BACTERIA BY POLYMORPHONUCLEAR 
LEUCOCYTES.
5,1. POLYMORPHONUCLEAR LEUCOCYTES
In 1883, Elie Metchnikoff injected foreign particles into metazoans, 
and observed that they were taken up by 'wandering mesodermal cells' 
that resided in interstitial tissues. He named these 'phagocytes', 
and twenty years passed before he observed and realised that the 
phagocytic cell was capable of intracellular killing of bacteria 
(Metchnikoff, 1905). The predominant phagocytic white cells are the 
circulating PMNs. Polymorphonuclear leucocytes are produced in the 
bone marrow from a stem cell pool. The stem cell-pool is believed to 
be pluripotential, the common ancestor of erythrocytes and platelets 
(Dunn, 1971). The evolution from stem cell to mature blood PMN takes 
approximately 13-14 days.
The number of PMNs entering the blood stream each day from the bone 
marrow is 10*. Half of these are not circulating, but are adherent to 
the endothelium, a process called margination. The mechanism of 
adhesion is not precisely known, but involves both net surface 
negative charges (Hoover et al. 1978) and physical contact with the 
substrate (Malech, Root and Gallin, 1977). The cell surface charge 
may allow cells to be drawn to each other so that microfilament 
attachment can occur. Polymorphonuclear leucocytes enter the tissues 
from the bloodstream where they fulfil their functional role. They 
have no regenerative capacity, and do not return to the circulation, 
as do mononuclear phagocytes. The total life span of a PMN is about
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15 days. The PMN has a characteristic large multilobal nucleus (Fig 
XXVI) and numerous cytoplasmic granules, which appear pink using 
Leishman stain. The azurophil or primary granules appear early in 
development at the promyelocyte stage, with a rich content of acid 
hydrolases. The specific or secondary granules appear at a later 
stage, and are 3 times as numerous as the primary granules. They are 
called specific since they contain lactoferrin and cobalophilin which 
are regarded as specific cytochemical markers in PMNs. They are also 
smaller and lack digestive enzymes and peroxidase. When a particle is 
phagocytosed the granules are released sequentially into the 
phagosome, the specific granules being discharged first, followed by 
the azurophils. Granule contents may also be released by granule 
fusion with the plasma membrane rather than with a phagosome, which 
may be important in the destruction of large pathogens which are not 
easily ingested. This may also have tissue-damaging effects at for 
example, sites of immune-complex deposition, where released PMN 
products may be a major cause of tissue destruction.
The PMN is a specialised cell designed for adhesion, movement, 
ingestion and intracellular killing of microbes. It also behaves as a 
scavenger cell, removing products of tissue damage and breakdown, and 
dead or dying cells from the circulation. Its task is primarily 
migration to the site of injury, where it responds with a significant 
release of lysosomal constituents and the production of oxygen 
radicals, therefore having the potential to cause some tissue damage.
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5.2. PHAGOCYTOSIS
Phagocytosis is the process whereby single cells internalise objects 
that they encounter (Fig. XXVII). The process is a matter of survival 
for unicellular organisms, which use it to gain nourishment. In 
higher animals it protects against invasion by micro-organisms in the 
internal and external environment.
As part of a response to infection there is an increase in PMN 
production, a leucocytosis. This is associated with acute 
inflammation and marked in infections with ’cocci’, especially if they 
are generalised (Harkness, 1981). Vigorous exercise and adrenalin are 
physiological factors, causing leucocytosis by shifting the cells from 
marginal sites. Such a leucocytosis is not accompanied by an increase 
in the total number of PMNs in the body.
Chemotaxins attract the circulating PMNs to the infection site 
(details in chapter 3), whereas monocytes arrive at a slower pace. 
Greater motility thus results in the prompt response of chemotactic 
stimulation relative to monocytes. This however could not explain why 
this reaction stops once the mononuclear cell infiltrate is 
established. Explanations could be that inhibitors of PMN motility 
could accumulate, or that PMNs may have a higher response threshold 
than that of monocytes to chemotaxins. Then as these chemotaxins are 
absorbed or inactivated by cells in the exudate, their concentrations 
may fall below that response threshold.
Having arrived at the site of an invading bacterium, phagocytes need
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to recognise it, i.e. they use specific receptors to bind to the 
surface of the bacteria. Opsonins coat the bacterium to produce this 
recognition. Wright and Douglas (1903) originated the term opsonise 
from the Greek, meaning 'to prepare for dining'. Immunoglobulin G 
(lgG) and C3b are the primary opsonins which bind PMNs to bacteria and 
promote ingestion. This is because PMNs and monocytes have receptors 
for the Fc portion of IgG and for the C3b part of the complement 
factor (Horvitz, 1982). The subclasses IgGi and IgG3, of the serum IgG 
antibody are the species which participate in opsonisation. The 
presence of specific antibody as an opsonin is known as immune 
opsonisation. Both the Fc portion and the Fab segment of the antibody 
must be intact for expression of opsonic activity (Quie, 1972). Since 
the IgG immunoglobulins are heat-resistant, the heat stable opsonic 
activity of serum is due to the presence of antibodies. Normal 
serum has little heat-stable opsonic activity, whereas heat-labile 
opsonic activity can be entirely attributed to the complement-protein 
C3b. Certain organisms do not require antibody or complement for 
phagocytosis to occur, namely non-encapsulated pneumococci and many 
gram-negative bacilli. Other bacteria, particularly encapsulated ones 
such as klebsiella and virulent strains of S . aureus escape 
phagocytosis unless antibody and/or complement is present, thus 
contributing to their pathogenicity.
Attachment of the opsonised particle to the phagocyte induces the 
formation of pseudopods which surround the particle as a result of 
interactions between surface receptors, termed the 'zipper mechanism' 
(Griffin et_al, 1975). The pseudopodia then fuse and engulfment is 
completed with the formation of a phagosome. The action of the
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contractile proteins moves the phagosome through the cyloplasm to the 
region of the Golgi apparatus, where several small vesicles, the 
primary lysosomes, fuse with the phagosome and form a phagolysosome. 
This process is called degranulation, a mechanism whereby enzymes are 
delivered to their operational sites without subjecting the PMN 
cytoplasm to their potential injurious effects. The phagolysosome 
contains many hydrolytic enzymes, including proteases, nucleases, acid 
phosphates and lipases which attack the ingested material. As a 
result of this metabolic activity and the additions of specific 
granule contents, the pH inside the phagolysosome increases slightly 
then falls (Segal et al. 1981), then a series of biochemcal changes 
occur that result in the killing of ingested material (Root and Cohen, 
1981). (See Fig. XXVIII).
The microbicidal activity of PMNs can be divided into 1) oxygen- 
dependent and 2) oxygen-independent systems.
The oxygen-dependent process involves a coordinated series of 
metabolic events, dormant in resting cells, whose function is to 
produce a group of highly reactive microbicidal agents by the partial 
reduction of oxygen. This 'respiratory burst1 is described in detail 
in chapter 4.
The oxygen-independent mechanisms are responsible for microbial 
killing in an anaerobic environment or in PMN where the oxidative 
capacity is deficient or absent e.g. chronic granulomatous disease. 
These mechanisms are -
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Fig XXVIII Diagram showing phagocytosis and intracellular digestion.
1) The acidic environment of the phagolysosome (pH 4.0 to 6.0).
2) Lactoferrin, an iron-binding protein whose extracellular release can 
destroy microbes by starving them of iron (Root and Cohen, 1981).
3) The direct action of lysozyme, which attacks the peptidoglycan of
some bacterial walls, resulting in the lysis of the microorganisms 
(Unanue, 1976).
Primary granules are rich in arginine which rapidly affects the ability 
of bacteria to replicate without destroying their structural 
integrity. In addition PMNs contain a variety of proteases and 
hydrolases which have a digestive rather than a microbicidal function 
(Klebanoff and Clark, 1978).
Oxygen-dependent and oxygen-independent mechanisms tend to be studied 
separately, and little is known about their interactions. A 
cooperative attack of oxidants and hydrolytic enzymes may be 
possible whereby the exposure of bacteria to a free radical-generating 
system would increase their susceptibility to attack by lysozyme 
(Thomas, Lehrer and Rest, 1988).
5.2.1. Measurement of phagocytic activity
The process of phagocytosis may be examined in vivo and in vitro. The 
latter offers several advantages, namely:
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1. Known homogenous populations of phagocytic cells can be separately 
studied
2. Effect of serum, and of other factors, on phagocytic function can 
be assessed, and
3) Phagocytic uptake can be evaluated independently of bacterial
killing. The use of subjective techniques, such as microscopic 
examinations of smear preparations and colony counting, have 
several disadvantages in that they are tedious, time consuming 
and subject to interobserver error. The radiometric assay, 
(chapter 2.7), however is an objective and sensitive assay which 
can be quantitated so that results may be obtained within 
several hours. There often lacks distinction in these assays 
between intracellular ingestion and extracellular attachment, 
therefore care must be taken in interprepation of the results. 
Polymorphonuclear leucocyte killing can be measured directly by 
the decrease in number of live bacteria, by radio-active probes 
or by microbiological methods. The respiratory burst which 
accompanies PMN phagocytosis is an indirect measurement of the 
microbicidal activity of these cells. However non-specific 
activation accompanied by a metabolic burst may not necessarily 
be accompanied by intracellular killing, therefore this type of 
measurement would be unsuitable in the estimation of phagocytic 
ability.
In this study the intention is to evaluate and compare the phagocytic
uptake of various gram-negative bacteria by PMNs from patients with
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AS, normal controls and from HLA-B27 negative and HLA-B27 positive 
normal individuals without disease.
5.3 COMPARISON OF HEAT-STABLE AND HEAT-LABILE
OPSONINS IN THE UPTAKE OF K. pneumoniae BY 
POLYMORPH ONI in .FAR LEUCOCYTES.
The best described opsonins are antibodies, which are heat stable and 
thus add an element of specificity to the phagocytic process, and 
complement, which is heat labile and non- specific. This experiment 
was devised to establish whether the opsonisation of K. pneumoniae was 
complement or antibody mediated. The classical complement pathway is 
activated when a specific antibody, e.g. IgG binds to the bacterium 
(antigen) by its antibody binding site (Fab fragment), leaving the Fc 
fragment exposed. The binding of Clq protein to this fragment leads 
to a subsequent cascade of enzymatic reactions which results in the 
deposition of certain fragments, C4b, C2a, C3b, C5b, and C6 through 
C9, on to the bacterial cell wall. Bacteriolysis results, but the 
precise mechanism is still not known. However there is good evidence 
that activation of complement components on the cell surface results 
in the formation of physiologicalholes in the cell membrane, leading to 
osmotic lysis of the cell (Provost and Allen, 1976). Activation of 
the alternate complement pathway does not require whole antibody 
molecules. Bacterial endotoxins alone can stimulate the late 
components of complement.
The heat-labile complement, in particular the C3b fragment acts 
primarily by adhering to the antigen and then binding the antigen to 
lymphocytes and phagocytic cells by C3b receptors on the cell surface 
(Stossel,1974), activating the cell and enhancing phagocytosis.
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5.3.1. Materials and Methods
Six aliquotes of NPS were prepared, three of which were heated in a 
waterbath at 56°C for 30 minutes. Heparinised blood was collected 
from 3 AS patients, and PMNs separated by dextran sedimentation. A 
radiometric phagocytic uptake assay was performed (2.7), to evaluate 
percentage uptake, when K. pneumoniae was opsonised with NPS, and 
heat-treated NPS.
5.3.2. Results
When NPS was heat-treated at 56°C for thirty minutes percentage uptake 
was drastically reduced compared to percentage uptake achieved with 
unheated NPS, showing the complement to be heat-labile.
NPS Heat-treated NPS
9.43 5.93
13.28 4.84
12.33 1.88
This clearly showed that opsonisation of the bacterium with complement 
mediated serum was required to achieve a more efficient phagocytic 
uptake. This would support the theory that the functional properties 
of the cleavage products of complement activation are more important 
than are the actual bacteriolytic reactions, in host defence against 
infection (Upjohn, 1975).
67
5.4 COMPARISON OF PHAGOCYTIC UPTAKE OF K
pneumoniae K43 AND P. mirabilis BY 
POLYMORPHONUCLEAR LEUCOCYTES FROM 
ANKYLOSING SPONDYLITIS PATIENTS AND 
FROM NORMAL INDIVIDUALS.
5.4.1. Mater ials and Methods
Heparinised blood was collected from 16 AS patients and from 10 
controls. Details of samples are as follows:
AS Patients Normals
No. of Samples 16 10
Mean age (Yrs) 40 29
range (20 - 62) (19-40)
M 12 5
Sex
F 4 5
A radiometric assay was used to evaluate percentage uptake of the 
bacteria, as decribed in chapter 2.7, using purified PMNs (see 2.3) 
from AS patients and normal controls, opsonised with normal pool serum 
(see 2.7.2.). A Mann Whitney test was used to analyse the results, 
which are expressed as medians and interquartile ranges.
5.4.2. Results
A significantly enhanced uptake of K. pneumoniae by AS PMNS was shown, 
compared to normals (P = .009). No difference was seen between AS 
PMNs and normal PMNs in the uptake of P. mirabilis (Fig XXIX).
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UPTAKE - K43, PROTEUS
10 Norm and 16 AS
% uptake 
50-
40-
30-
20-
10-
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Fig XXIX
p = 0.69
[~1 Normal 
YA AS patients
p = 0.009
K43 Proteus
Comparison of phagocytic uptake of K. pneumoniae (K43) 
and P. mirabilis (Proteus)by polymorphonuclear cells 
from AS patients and normals.
Expressed as medians and interquartile ranges.
However not all patient and normal samples were assayed 
simultaneously, therefore assays were repeated using 30 AS patients 
and 28 controls, care being taken to assay both patient and normal 
samples together to minimise any inter-assay variation.
5.5. PHAGOCYTIC UPTAKE OF K. pneumoniae AND P.
mirabilis BY PMNS FROM 30 AS PATIENTS AND 28 
NORMAL CONTROLS.
5.5.1. Materials and Methods
Samples were collected in heparin, and both AS PMNS and normal PMNS 
were assayed simultaneously, see 2.7. Details of samples are as 
follows:
AS Patients Normal
No. of SamDles 30 28
Mean aae (vrs) 41 29
range (27-69) (24-57)
M 25 17
Sex
F 5 11
5.5.2. Results
Results are expressed as medians and inter-quartile ranges, and P.
values were calculated using a Mann Whitney test, (Fig XXX). No
difference was shown in uptake of K. pneumoniae or P. mirabilis
between AS PMNs and normal PMNs.
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Fig XXX Comparison of phagocytic uptake of K. pneumoniae and 
P. mirabilis by polymorphonuclear cells from 30 AS 
patients and 28 normals.
Expressed as medians and interquartile ranges.
Our initial findings of enhanced uptake of K. pneumoniae by AS PMNs to 
normals was therefore not confirmed, due perhaps to patient and normal 
samples not being processed together in the first series of assays, 
and to small numbers.
PHAGOCYTIC UPTAKE OF Y. enterocolitica AND S. 
tVDhimurium BY PMNS FROM AS PATIENTS AND 
NORMAL CONTROLS.
5.6.1. Materials and Methods
Using the same radiometric assay, the phagocytic uptake of Y. 
enterocolitica in 18 AS patients was compared to that of 10 normals 
and the uptake of S. typhimurium in PMNs from 10 AS patients and 10 
normals was examined. Details of samples are as follows:
Y. enterocolitica S. typhimurium
No. of AS Patients 18 10
Mean aae(yrs) 45 38
range (33-65) (29-59)
M 14 9
Sex
F 4 1
No. of Normals 13 10
Mean Age (yrs) 28 28
range (22-55) (22-43)
M 10 7
Sex
F 3 3
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5.6.2. Results
Again, no difference was seen in phagocytic uptake of either Y. 
enterocolitica or S. typhimurium between AS patient and normal PMNs. 
(Figs XXXI, XXXII).
Sera was collected from several AS patients, then pooled and frozen in 
aliquots at -70°C. These aliquots were used to opsonise the bacteria 
in place of the normal pool serum.
5.7.1. Materials and methods
10ml of peripheral blood was collected in heparin from ten AS patients 
and from nine controls.
OPSONIC CAPACITY OF AS SERA
AS patients Normals
No. of Samples 10 9
Mean age (yrs) 
range
41
(23-59)
31
(22-40)
M 9 5
Sex
F 1 4
Cells were separated and bacteria opsonised with AS pool sera. 
Phagocytic uptake of K. pneumoniae and P. mirabilis was then
evaluated.
UPTAKE - Y. enterocolitica
13 norms and 18 AS
% uptake
P = 0.3
50-
40-
30-
20 -
10-
Normal AS
XXXI Comparison of phagocytic uptake of Y. enterocolitica 
by polymorphonuclear cells from 13 normals and 18 
ankylosing spondylitis patients.
Expressed as medians and interquartile ranges.
UPTAKE - S. typhimurium
10 norms and 10 AS
% uptake
60i
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Fig XXXII Comparison of phagocytic uptake of S. typhimurium by 
polymorphonuclear from 10 normals and 10 ankylosing 
spondylitis patients.
Expressed as medians and interquartile ranges.
5.7.2. Results
Results were expressed as medians and interquartile ranges (Fig 
XXXIII). No significant difference was found, in the phagocytic 
uptake of gram-negative bacteria, between AS patient and normal PMNs, 
when the bacteria were opsonised with pooled serum prepared from 
several AS patients rather than a normal pool serum. Also no 
impairment in the opsonic ability of AS serum was shown as uptake 
values were comparable to those obtained in previous assays where 
bacteria were opsonised with a pooled serum from normal individuals.
5.8. COMPARISON OF PHAGOCYTIC UPTAKE OF GRAM-
NEGATIVE BACTERIA BETWEEN HLA-B27 POSITIVE 
AND HLA-B27 NEGATIVE NORMAL INDIVIDUALS.
Because of the HLA-B27 - AS link, it was also important to examine 
PMNs from HLA-B27 normal individuals.
5.8.1. Materials and methods
Samples of heparinised blood were collected from nine HLA-B27 positive 
and ten HLA-B27 negative normal volunteers, which were made available 
via the tissue-typing laboratory, Glasgow Royal Infirmary. PMNs from 
both B27 positive and B27 negative samples were assayed 
simultaneously, and phagocytic uptake of K. pneumoniae. P. mirabilis. 
Y. enterocolitica and s. typhimurium was examined. Details of samples 
as follows.
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UPTAKE - K4X PROTEUS - AS OPSONIN
9 Norm and 10 AS
% uptake
501 Normal 
AS patient p = 0.59
40-
30-
p = 0.96
20-
io-
K43 Proteus
Fig XXXIII Comparison of phagocytic uptake of K. pneumoniae (K431 
and P. mirabilis (proteus) by polymorphonuclear cells 
from 9 normals and 10 AS patients, when bacteria has 
been opsonised with AS pooled sera.
Expressed as medians and interquartile ranges.
HLA-B27 + ue HLA-B27 - ue
No. of Samples 9 9
Mean aae(yrs) 
range
31
(24-43)
35
(29-42)
M 6 2
Sex
F 3 7
5.8.2. Results
Results were analysed using a Mann Whitney test and expressed as 
medians and interquartile ranges. Again no difference was expressed 
between B27 positive and B27 negative PMNs, in the case of all four 
bacteria. (Fig XXXIV).
5.9. AGE AND UPTAKE mRRFT.ATTON
The ages of 19 normals were correlated with the phagocytic uptake of 
K. pneumoniae, using a Spearman rank correlation test.
5.9.1. Results
The spearman rank correlation coefficient was found to be -0.29, 
indicating no correlation between age and phagocytic uptake. (Fig 
XXXV).
Significance level p = .21
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UPTAKE - K43, PROT.. YERS.. SALM.
9 B27 -ve and 9 B27+ve
% uptake
501 p = 0.06
p = 0.640-
30-
p = 0.5p = 0.1
20-
io-
K43: Yers SalmProt
Fig XXXIV Comparison of phagocytic uptake of gram-negative bacteria 
by polymorphonuclear cells from HLA-B27 positive and 
negative normals.
K43: K. pneumoniae Prot: P. mirabilis
Yers:Y. enterocolitica Salm: S. typhimurium
% 
UP
TA
KE
CORRELATION of AGE and UPTAKE
60 n
Sr C = - .29
50-
40-
30-
20 -
3 0 40 50 602 0
AGE
XXXV Correlation of phagocytic uptake and age in 19 
normals.
Spearman rank coefficient (SrC) = -.29 
Significance level P = .21
5.10 CONCLUSIONS
Despite an initial enhancement of the phagocytic uptake of K. 
pneumoniae by AS PMNs being shown, this was not confirmed as 
experimental numbers were increased. This may be a consequence of 
samples not being assayed simultaneously in the first series of 
assays. Subsequently both patient and normal samples were examined 
together to eliminate any interassay variables. As with K. 
pneumoniae, no difference was shown in the phagocytic uptake pf P. 
mirabilis, Y. enterocolitica and S. tvphimurium between AS patient and 
normal PMNs. Also no defect was shown in the ability of AS serum to 
opsonise bacteria in preparation for phagocytosis. Finally HLA-B27 
positive samples also showed no defect in phagocytic capacity. 
Therefore although significant CL activity was shown in AS samples 
compared to normals in chapter 4, it would appear that this is not 
indicative of the phagocytic ability of AS PMNs. It may be that the 
use of purified PMNs in these assays may mask any defect due to pre­
activation of PMNs. However defective phagocytic ability has been 
shown in the PMNs of rheumatoid arthritis patients, using the same 
radiometric assay (Frame, Ph.D, Thesis 1989). This will be discussed 
further in chapter 6.
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CHAPTER 6 DISCUSSION AND FUTURE RESEARCH
Ankylosing spondylitis is a seronegative inflammatory disorder where 
more than 90% of patients possess the histocompatability antigen HLA- 
B27. Although this association is very striking it is not absolute, 
and studies have suggested that either the B27 antigen in individuals 
with spondylitis is different from that in individuals without 
disease, or that an additional factor(s) is also present in the 
spondylitic families.
Bacterial triggers are thought to play an important role in the 
aetiopathogenesis of the disease and serological cross-reactivity has 
been shown between a determinant on HLA-B27 positive spondylitic cells 
and certain gut bacteria.
One of the principle functions of neutrophils and mononuclear 
phagocytes, which migrate into the tissues during the inflammatory 
response, is the internalisation of material by the process of 
phagocytosis. This process acts as a first line in host defence 
mechanisms against invasion by microorganisms. Polymorphonuclear 
leucocytes are the most numerous of phagocytes in the blood and are 
easy to obtain in high yield and purity. They also appear to be 
homogeneous, i.e. the majority behave alike under stimulation, 
rendering them most suitable for in vitro study.
Hence this thesis investigated the function of PMNs in ankylosing 
spondylitis by examining three different aspects of PMN behaviour.
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i) Polymorph migration, both random and directed.
ii) Chemiluminescence response to bacterial stimulants.
iii) Ingestion of bacteria.
The results of each aspect of PMN functions are discussed in the same 
order of presentation throughout this thesis.
Chemotaxis
Polymorphonuclear leucocytes move either randomly, or directionally in 
response to a chemotactic stimulus, towards a site of injury or
imflammation. This activity can be studied in vitro by migration
under agarose (Nelson et al. 1975), or by migration through a 
polycarbonate membrane filter (Falk et al. 1980). The latter has been 
used by means of a 48-well micro-chemotaxis chamber assembly, a
modification of the Boyden chamber. (See chapter 2.).
This method had been previously standardised in our laboratory, and 
has several advantages over other chemotaxis methods, these include,
i) Reduced time to perform the assay.
ii) Volume of chemotactic factor required is small.
iii) Number of cells needed is low.
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iv) Larger numbers of samples may be tested in parallel.
Results show a slight increase in random motility in AS patients 
compared to normals, but this increase was not statistically 
different, (Fig X). Pease et al. 1984 used both an agarose plate
method and micropore filter method, and found that random motility 
varies with different techniques.
An increased directional chemotactic response to zymosam-activated 
serum was noted in our study in AS PMNs compared to normal PMNs. but 
again this was not statistically significant (Fig XIII). This
confirms the results of Mowat, 1978 who also detected no significant 
differences in motility between AS and normal PMNs, using a filter
technique. In contrast to this Pease et al. 1984 and 1989, showed a
statistically significant increase in the directional motility of AS 
PMNs compared to normal PMNs, by means of both filter and agarose 
plate technique run in parallel.
In results from subsequent work in CL response we showed that normal 
PMtfe were pre-activated during our separation procedure, thus possibly 
causing any inherent differences between AS and normal PMNs to be 
masked. In our chemotaxis studies dextran sedimentation was used to 
isolate PMNs, whereas Pease et al used a one-step density gradient 
technique which avoids the use of dextran sedimentation and osmotic 
shock (Ferrante and Thong, 1978), thus perhaps avoiding any basal 
activation. This may account for differences between the two studies.
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However this one-step gradient technique fails to completely purify 
PMNs from the mononuclear fraction, hence making recovery of pure 
fractions difficult. Pease et al failed to mention cell purity in
their work.
Recently, a modification of the Ferrante and Thong separation 
technique has been developed in the Department of Medicine, which 
provides an improved separation of pure sub-fractions. (Lennie et a l . 
1987). Parallel investigations into different separation techniques 
and subsequent examination of PMN migration may thus prove useful in 
future research.
It has been suggested that chemotactic ability may be determined by 
the presence of the HLA-B27 haplotype (Leirsalo et al. 1980). A study 
was therefore undertaken to compare B27 positive and B27 negative 
normal individuals. No difference in PMN migration was observed 
between these two groups (Fig XII). This was supported by Pease et al 
who did not find any difference between B27 positive and negative 
controls. A recent report from Finland suggests that enhancing
migratory capacity of HLA-B27 positive sera, decribed by Leirsalo et
al. 1980, is not genetically determined, but is acquired secondarily,
since the chemokinetic activity of sera from B27 positive children was 
found to be similar to that of B27 negative children; but in adults 
migration distances were greater in B27 positive individuals, although 
not in a statistically different way. (Repo et al . 1988).
Although most groups have used either zymosan-activated serum or
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casein chemotaxis, it would seem more appropriate to use bacteria or 
bacterial products as chemotaxins. We therefore tested several gram- 
negative bacteria in this respect. Neither formalin-treated nor 
sonicated bacteria stimulated chemotaxis, and similarly whole bacteria 
showed no chemotactic qualities. However bacterial culture filtrates 
did produce a chemotactic gradient, indicating the possible production 
of a chemotactic substance during the logarithmic growth phase of a 
bacterium. The chemotactic abilities of culture filtrates of Y. 
enterocolitica and Sj_ tvohimurium were no different from MH broth, 
the preparation medium. However pneumoniae culture filtrate did 
show a higher chemotactic response than MH broth, suggesting that some 
product of this bacterium was behaving as a chemotaxin for PMNs from 
both normal and AS patients. No difference in motility was apparent 
between normal and AS PMNs, irrespective of the culture filtrate used 
(Fig XI).
Finally, no correlation was shown between directional PMN motility in 
AS patients and disease activity (Fig XV), as was similarly reported 
by Pease et al 1984. Nor was any correlation determined between PMN 
motility and age (Fig XIV), which has not been previously reported.
Chemiluminescence response
As a result of stimulation of the phagocytic membrane during 
phagocytosis of micro-organisms, there is an abrupt increase in oxygen 
consumption followed by the production of various reactive oxygen 
intermediates. There is also an increase in the oxidation of glucose 
via the hexose monophosphate shunt pathway. These changes in
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via the hexose monophosphate shunt pathway. These changes in 
oxidative metabolism are collectively known as the 'respiratory 
burst', and can be measured by oxygen consumption and oxidising 
radical production.
Purified cell preparations are usually used in chemiluminescent 
studies, so the intial experiments carried out in this work were done 
using purified PMNs, and I found no difference in CL response between 
AS patients and normals, when PMNs were stimulated with opsonised 
bacteria. An alternative technique was therefore examined to confirm 
these findings. A CL emission may also be detected using whole blood 
in microlitre quantities, and an assay was developed by Kato et al. 
1981, and Herberer et al. 1982 which gave a rapid evaluation of 
phagocytosis-induced metabolic respiratory burst which would reflect 
phagocytic functions in vivo.
A series of assays was therefore run in parallel, examining CL 
response of AS patients and normals to bacterial stimulation using 
both purified PMNs, separated by dextran sedimentation, and whole 
blood PMNs. Results again showed no difference when purified PMNs 
were used. However a statistically significant difference was shown 
when whole blood was used from the same samples, i.e. ankylosing 
spondylitis patients showed a significantly increased CL response to 
stimulation from a series of gram-negative bacteria. This inferred 
that something had been happening during the separation procedure, 
therefore basal CL response was examined, i.e. CL response emitted 
from PMNs to which no stimulators had been added. A significant 
difference was shown between whole blood PMNs from AS patients
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compared to normals, whereas when purified PMNs were used no 
difference was detected. This increased basal CL response may reflect 
an in vivo pre-activation of AS whole blood PMNs, a theory supported 
by Brinch et al,, 1982, who showed the complement system in AS 
patients to be activated. Our separation technique therefore appeared 
to preactivate normal control PMNs, thus eliminating any difference in 
CL response. This pre-activation of PMNs has also been shown to occur 
in patients with a current bacterial infection, (Barbour et al. 1980, 
Kohashi et al, 1987), compared to normals, or to patients with a viral 
infection.
Tatsuhito et al. 1983 also showed a basal or background CL to be 
elevated in patients with bacterial infection. Interestingly Mowat 
and Baum (1971) showed an impairment in CX in these patients, 
suggesting a prior phagocytosis of antibody - antigen complexes by 
PMNs.
Consequently all our subsequent assays were performed using a whole 
blood assay and the CL response of PMNs from AS patients, to various 
stimuli, was compared to normals. Ankylosing spondylitis patients 
PMNs showed a significantly increased CL response to several 
arthritogenic gram-negaive bacteria, and also to P. mirabilisr a gut 
bacterium not normally associated with AS. This may indicate a pre­
disposition of AS PMNs to these bacteria, which could be explained by 
an increase of bowel permeability in AS patients (Smith, Gibson and 
Brooks, 1985).
This phenomenon was shown not to be specific to all chronic 
inflammatory disorders, since PMNs from rheumatoid arthritis patients
showed neither any increased basal CL response nor any increased CL
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response to gram-negative bacteria. Stimulation with the gram- 
positive bacterium S. aureus however produced a significantly enhanced 
CL response from patients with rheumatoid arthritis compared to 
normals. This is not wholly surprising in view of there being an 
increased incidence of S . aureus infection in rheumatoid arthritis 
patients. Ankylosing spondylitis PMNs also showed an increased CL 
response when stimulated with S. aureus, indicating that gram-negative 
bacterial triggers, in vivo, may contribute to an enhanced CL response 
in AS patients, which is non-specific.
These were in contrast to results by El Abbouyi et al (1988) who found 
a reduced CL response in AS PMNs compared to controls, when opsonised 
zymosan was used as a stimulant. However they examined only 12 
patients and used separated PMNs in their study.
When unstimulated PMNs from HLA-B27 positive and B27 negative normals 
were examined, followed by stimulation with K . pneumoniae. Y 
enterocolitica and finally with PMA, B27 positive normal PMNs showed a 
slightly increased CL response, but this was not statistically 
significant. This suggests that enhanced activation develops with 
disease, rather than being associated with HLA status.
Phagocytes possess externally disposed plasma membrane receptors for 
many substances, and the binding of agonists to these receptors is the 
initial step in the series of actions that result in chemotaxis, 
phagocytosis and activated oxygen radical production. It is possible 
that this enhancement of CL response in AS PMNs may be due to an 
abnormality of membrane receptors, located on the cell membrane. A
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abnormality of membrane receptors, located on the cell membrane. A 
clue to the involvement of HLA-B27 may lie in its possible role as a 
receptor for some environmental agent. However since an increased CL 
response was also found in AS PMNs when PMA was used as an activator, 
this abnormality may also be due to extrinsic factors, as PMA does not 
act through specific cell surface receptors, but reacts directly with 
Protein Kinase C at a point distal to the cell surface via a different 
activation pathway, (Nishihira and O'Flaherty, 1985).
Future research might include incubation of AS PMNs in normal serum 
and vice versa before examination of CL response, to see whether or 
not this abnormality shown may be due to either, a modification of 
membrane receptors or to a disorder in the transduction of the 
activating signal.
Phagocytic Uptake
Phagocytosis is the act of internalisation and the subsequent 
sequestration, into phagosomes,of extracellular particulate matter.
In vitro cell assay systems were utilised throughout this study in 
the assessment of phagocytic uptake of radio-labelled bacteria by both 
AS and normal PMNs. Advantages over the in vivo methods include:
1. Elimination of some of the clinical and immunological variables 
inherent in patient-orientated studies.
2. Known homogenous granulocyte cell populations can be used; and
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3. The process of phagocytosis and intra-cellular killing can be 
assessed independently of each other.
This work measured only phagocytic uptake, although current work in 
this department is now underway, examining the killing ability of PMNs 
from various patient groups.
This study clearly showed that phagocytic uptake required that 
bacteria were opsonised with complement-mediated serum (chapter 5.3), 
supporting the theory that functional properties of the cleavage 
products of complement activation are more important than the actual 
bacteriolytic reactions, in host defence against infections (Upjohn, 
1975).
No correlation was found between age and phagocytic ingestion, 
confirming a large study which revealed that PMNs from older subjects 
were no less efficient phagocytes than controls (M. Frame, Phd thesis, 
1989).
A total of 58 AS patients were examined for phagocytic uptake of 
various gram-negative bacteria; neither an enhancement nor a decrease 
in the phagocytic ability of AS PMNs was shown, compared with normals. 
This may be due to the use of purified PMNs in these assays, 
concealing any inherent defect, as a result of pre-activation of the 
PMNs, determined in our subsequent studies in chemiluminescence 
response.
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Other studies, which utilised separation of PMNs by dextran 
sedimentation, attested that PMNs from rheumatoid arthritis patients 
revealed intrinsic cellular defects including impaired phagocytic
ingestion, compared to normals, using a radiometric assay^
(m . Frame Phd thesis, 1989). However, preactivation of PMNs
would be unlikely to mask any visible inherent defect in rheumatoid
patients, as it does enhancement of activity in AS patients.
No abnormality was found in the opsonic ability of AS serum (Fig 
XXXIII). Polymorphonuclear leucoytes from HLA-B27 positive and 
negative normals were also compared for phagocytic uptake efficiency, 
and again no difference was determined (Fig XXXIV).
No other large study has examined phagocytic uptake in ankylosing 
spondylitis patients.
An abnormality in phagocytic function may have been expected due to 
the pre-activation of AS PMNs shown in the CL study. Having
established this pre-activation it might be appropriate to repeat some 
uptake work, using either a different PMN separation procedure, or 
attempting to modify the radio-metric assay to use whole blood 
fractions, thus preventing any in vitro stimulation of normal PMNs.
Ankylosing spondylitis affects predominantly the sacroiliac joints and 
the spine, although other joints may be involved in up to 35% of 
patients, mainly hips or shoulders. Spread of the disease to the 
more peripheral joints e.g. the knees, occurs much less frequently. 
Therefore data on synovial fluid from AS patients is difficult to
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obtain. Kendall et al, 1973 found the lymphocyte count and
immunoglobulin levels were significantly higher in AS patients 
compared to a group with rheumatoid disease and to a second group with 
osteoarthritis. Current work is being undertaken in this laboratory, 
examining the CL response of synovial fluid PMNs from AS patients, 
compared to Rheumatoid patients and to another group of sero-negative 
patients e.g. psoriatic arthritis, reactive arthritis, to various 
stimuli. Initial results indicate no significant difference in CL 
response between AS synovial fluid PMNs and PMNs from either of the 
other two groups. An increase in the lymphocytes however was 
determined in the differential white cell counts in AS synovial fluid, 
as indicated by Kendal et al. 1973, compared to the white cell counts 
in the rheumatoid patient group, but numbers are too small to 
determine whether or not this increase is statistically different. 
These initial results suggest a vigorous lymphocyte response at sites 
of inflammation, which could in turn reflect what is occurring in the 
sacroiliac joints in AS patients.
In summary this thesis has shown that an initial membrane excitation 
of PMNs from AS patients is significantly greater than from normal 
PMNs, following bacterial stimulation. In contrast, PMNs from 
rheumatoid arthritis patients showed no abnormal reactions when 
stimulated with gram-negative bacteria, although S. aureus did produce 
an increased CL response, due probably to this bacteria being a common 
cause of minor infections in these patients. This may indicate some 
gut-inflammation in AS patients, rendering them more susceptible to 
invasion by gram-negative bacteria associated with the gut, thus
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activating host defence mechanisms and producing pre-activation of 
PMNs.
Granfors et al. 1989 demonstrated that microbial antigens can be found 
in the synovial fluid cells of patients with reactive arthritis after 
yersinia infection and suggested that as bacterial polysaccharides are 
relatively resistant to digestion, they may persist within phagocytic 
cells for long periods. Therefore studies in synovial fluids from AS 
patients should be part of a subsequent research project, where PMNs 
could be examined for the presence of bacterial antigens.
This thesis supports a role for gram-negative bacteria in the 
aetiopathogenesis of ankylosing spondylitis, but as yet this role is 
undetermined.
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